Meet Elizabeth Grubbs, M.D.
Elizabeth Gardner Grubbs, M.D.
Department of Surgical Oncology, Division of Surgery
Present Title & Affiliation
Primary Appointment
Professor, Department of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX
Associate Member, Graduate School of Biomedical Sciences, UT Health Graduate School of Biomedical Sciences, Houston
Dual/Joint/Adjunct Appointment
Professor, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Associate Member, Graduate School of Biomedical Sciences, UT Health Graduate School of Biomedical Sciences, Houston
Education & Training
Degree-Granting Education
| 2013 | Harvard University School of Public Health, Cambridge, Massachusetts, US, Epidemiology, M.S |
| 1999 | Duke University School of Medicine, Durham, North Carolina, US, MD |
| 1995 | Duke University Medical Center, Durham, North Carolina, US, Science in Biology, BS |
| 1995 | Duke University, Durham, North Carolina, US, Arts in Women's Studies, BS |
Postgraduate Training
| 2008-2008 | Clinical Effectiveness, Harvard University School of Public Health, Boston, Massachusetts |
| 2006-2008 | Clinical Fellowship, Surgical Oncology Fellowship, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 1999-2006 | Clinical Residency, Duke University Medical Center, Durham, North Carolina |
Licenses & Certifications
| 2007 | American Board of Surgery |
| 2006 | Texas Medical Board |
Experience & Service
Faculty Academic Appointments
Associate Professor, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2014 - 2020
Assistant Professor, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2008 - 2014
Administrative Appointments/Responsibilities
Executive Director of Faculty Academic Career Development, Department of Academic Affairs, Sr VP Office, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2024 - Present
Co-Director Leadership Institute, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2024 - Present
Director of Faculty Academic Career Development, Department of Academic Affairs, Sr VP Office, The University of Texas MD Anderson Cancer Center, Houston, TX, 2022 - 2024
Deputy Department Chair, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2021 - 2022
Vice Chair for Education, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2018 - 2024
Deputy Director of Education for the Division of Surgery, Department of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, 2017 - 2024
Program Director, Department of Complex General Surgical Oncology Fellowship, The University of Texas MD Anderson Cancer Center, Houston, TX, 2014 - 2022
Director, High Risk Hereditary Endocrine Neoplasia Center, Endocrine Center, The University of Texas MD Anderson Cancer Center, Houston, TX, 2012 - Present
General Surgery Residency Director, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2011 - 2014
Intramural Institutional Committee Activities
Executive Sponsor, Institutional Program Ascending Senior Faculty Academic Career Development Committee, The University of Texas MD Anderson Cancer Center, 2024 - Present
Executive Sponsor, Institutional Committee Promotion and Tenure Committee-Research, The University of Texas MD Anderson Cancer Center, 2024 - Present
Executive Sponsor, Institutional Committee Clinical Faculty Review Committee, The University of Texas MD Anderson Cancer Center, 2024 - Present
Executive Sponsor, Institutional Committee Promotion and Tenure Committee-Clinical, The University of Texas MD Anderson Cancer Center, 2024 - Present
Executive Sponsor, Institutional Committee Research Faculty Appointment Panel, The University of Texas MD Anderson Cancer Center, 2024 - Present
Executive Sponsor, Institutional Program Faculty Academic Career Development Academy, The University of Texas MD Anderson Cancer Center, 2024 - Present
Executive Sponsor, Institutional Committee on Faculty Required Training, The University of Texas MD Anderson Cancer Center, 2024 - Present
Executive Sponsor, Institutional Program Mid-Career Faculty Academic Career Development Committee, The University of Texas MD Anderson Cancer Center, 2022 - Present
Executive Sponsor, Institutional Program Established Senior Faculty Academic Career Development Committee, The University of Texas MD Anderson Cancer Center, 2022 - Present
Executive Sponsor, Institutional Program Junior Faculty Academic Career Development Committee, The University of Texas MD Anderson Cancer Center, 2022 - Present
Member, Promotion and Tenure Committee (PTC), The University of Texas MD Anderson Cancer Center, 2021 - 2024
Member, Internal Advisory Board for the Shared Decision Making Core, The University of Texas MD Anderson Cancer Center, 2021 - Present
Chair, Division of Surgery Education Committee, The University of Texas MD Anderson Cancer Center, 2017 - 2024
Chair, Program Evaluation Committee, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, 2014 - 2024
Member, Graduate Medical Educational Faculty Development Subcommittee, The University of Texas MD Anderson Cancer Center, 2014 - 2024
Member, Endocrine Steering Committee, The University of Texas MD Anderson Cancer Center, 2013 - Present
Member, Education Committee, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, 2011 - 2014
Member, Graduate Medical Education Committee, The University of Texas MD Anderson Cancer Center, The University of Texas MD Anderson Cancer Center, 2011 - 2022
Member, Graduate Medical Education Curriculum Subcommittee, The University of Texas MD Anderson Cancer Center, The University of Texas MD Anderson Cancer Center, 2011 - 2022
Editorial Activities
Member, Editorial Board of Surgery, 2020 - Present
Specialty Editor for MEN1 and MEN2, Cancer.Net, 2016 - 9999
Editor, Journal of Surgical Education, 2016 - 9999
Editor/Service on Editorial Board(s), Annals of Surgical Oncology, 2016 - 9999
Member of Editorial Review Board, OncoLog, 2011 - 9999
Honors & Awards
| 2024 - 2025 | Rated Top 1% Nationally, Clinician and Group Consumer Assessment of Healthcare Providers and Systems (CGCAHPS) |
| 2023 - 2024 | Rated Top 1% Nationally, Clinician and Group Consumer Assessment of Healthcare Providers and Systems (CGCAHPS) |
| 2022 - 2023 | Selected as a Fellow in the Hedwig van Ameringen Executive Leadership in Academic Medicine Program, Drexel University College of Medicine |
| 2019 | 2019 Best Masters of Health Professions Education Core Course Paper Award for paper entitled “Identifying Entrustable Professional Activities to Assess Complex General Surgical Oncology Fellows in Training", The University of Illinois at Chicago |
| 2019 | President’s Recognition of Faculty Excellence Awards for Education & Mentorship Advancement, The University of Texas MD Anderson Cancer Center |
| 2019 | Leadership Agility Program Award, Society of University Surgeons |
| 2019 | Selected to represent MD Anderson at the University of Texas Chancellor’s Network for Women’s Leadership Sponsorship Workshop, Austin, Texas |
| 2017 - 2018 | MD Anderson Top Performer, Rated Top 1% Nationally by the Clinician and Group Consumer Assessment of Healthcare Providers and Systems (CGCAHPS) |
| 2016 | Educator of the Month, October, The University of Texas MD Anderson Cancer Center |
| 2015 - 2023 | Representative to the Association of American Medical Colleges Mid-Career Women Faculty Professional Development Seminar, The University of Texas MD Anderson Cancer Center |
| 2014 | Resident Advocate Award, The University of Texas Health Science Center at Houston |
| 2008 | Fellow Competition for Best Paper, American Association for Endocrine Surgeons |
| 2003 | Resident's Forum, American College of Surgeons, NC Chapter |
| 2001 - 2003 | National Research Service Award, National Institutes of Health |
| 1998 | Finalist for Society of Obstetrical Anesthesiology and Perinatology's Gertie Marx Post-doctoral Fellowship Research Award |
| 1997 - 1998 | Howard Hughes Medical Institute Research Training Fellowship, Duke University School of Medicine |
| 1995 | Phi Beta Kappa |
| 1994 | NIH IRTA Fellowship, NIH |
| 1991 - 1995 | A.J. Tannenbaum Trinity Scholarship |
| 1991 - 1995 | Graduation with Distinction, Biology |
| 1991 - 1995 | National Merit Scholarship |
Professional Memberships
Selected Presentations & Talks
Local Presentations
- 2016. Advanced course on Surgical Oncology for The America’s. Conference. Advanced course on Surgical Oncology for The America’s. Houston, TX, US.
- 2016. Advanced course on Surgical Oncology for The America’s. Conference. Advanced course on Surgical Oncology for The America’s. Houston, TX, US.
National Presentations
- 2024. Year in Thyroidology. Invited. Chicago, IL, US.
- 2024. Operative Standards for Thyroid Cancer Surgery. Invited. ACS Clinical Congress. San Francisco, CA, US.
- 2024. Building the lifelong continuum in medical education. Invited. Dallas, TX, US.
- 2023. Medullary thyroid Cancer: what are the unanswered questions?. Invited. Denver, CO, US.
- 2022. Challenging Endocrine Surgical Cases. Invited. Cleveland, OH, US.
- 2022. How to create a rare tumor Registry. Invited, US.
- 2022. Oncology Training in Surgery: Are We Hitting the Mark in 2022?. Conference. Moderator. Dallas, TX, US.
- 2021. Thyroidectomy: Critical Elements and Intraoperative Decisions. Conference. 2021 Clinical Congress: Resilience in the Pursuit of Excellence. Virtual Meeting, US.
- 2021. Operative Standards and Intraoperative Decision Making: Thyroid Cancer. Invited, US.
- 2021. Medullary Thyroid Cancer: What is Next?. Invited, US.
- 2021. Moderator: Scientific Session 8. Conference. Moderator: Scientific Session 8. Virtual Meeting, US.
- 2020. Career Discussion: Practice Building - Lessons Learned in the First Few Years after Fellowship. Conference. Moderator, US.
- 2020. Thyroid/Parathyroid/Resection. Conference. Melanoma/Sarcoma/Endocrine Session, US.
- 2020. Pearls and Pitfalls of the Virtual Interview. Conference. Pearls and Pitfalls of the Virtual Interview. Virtual Meeting, US.
- 2020. THYCA: Medullary thyroid cancer: Medical management at the beginning of the journey. Invited. Los Angeles, CA, US.
- 2019. Moderator: Management of Hereditary Endocrine Syndromes. Conference. Moderator: Management of Hereditary Endocrine Syndromes. San Francisco, CA, US.
- 2019. AACE Medical Surgical Collaborative. Conference. AACE Medical Surgical Collaborative. Los Angeles, CA, US.
- 2018. Workup of Adrenal Incidentaloma. Conference. Workup of Adrenal Incidentaloma. Boston, MA, US.
- 2018. Medullary Thyroid Cancer – Updates on Detection, Management and Post-Operative Follow Up. Conference. Medullary Thyroid Cancer – Updates on Detection, Management and Post-Operative Follow Up. Washington, DC, US.
- 2018. The Changing Face of Thyroid Cancer Management for Surgeons: Real-Life Applications of the New ATA Guidelines. Conference. The Changing Face of Thyroid Cancer Management for Surgeons: Real-Life Applications of the New ATA Guidelines. Raleigh, NC, US.
- 2018. Contemporary Management of Thyroid Cancer. Conference. Contemporary Management of Thyroid Cancer. Chicago, IL, US.
- 2018. Medullary Thyroid Carcinoma in MEN2A: ATA Moderate or High-Risk RET Mutations Do Not Predict Disease Aggressiveness. Conference. The 2018 Academic Congress. Jacksonville, FL, US.
- 2017. Fundamentals of Surgical Research Course: Breakout Session Clinical/HSR. Conference. Fundamentals of Surgical Research Course: Breakout Session Clinical/HSR. San Diego, CA, US.
- 2017. Medullary Thyroid Cancer: A Surgically Treated Disease. Conference. Medullary Thyroid Cancer: A Surgically Treated Disease. Linthicum Heights, MD, US.
- 2017. Roundtable: Patient Reported Outcomes and Areas of Patient Concern About Medullary Thyroid Cancer. Conference. Roundtable: Patient Reported Outcomes and Areas of Patient Concern About Medullary Thyroid Cancer. Linthicum Heights, MD, US.
- 2017. Initial Staging and Management of MCT (Basic Primer in Management of MTC). Conference. Initial Staging and Management of MCT (Basic Primer in Management of MTC). Boston, MA, US.
- 2017. Medullary thyroid carcinoma registry: An essential tool in the study of a rare disease. Conference. Medullary thyroid carcinoma registry: An essential tool in the study of a rare disease. Durham, NC, US.
- 2016. Medullary Thyroid Cancer: A Surgically Treated Disease. Conference. Medullary Thyroid Cancer: A Surgically Treated Disease. Los Angeles, CA, US.
- 2016. Medullary Thyroid Carcinoma in MEN2A: ATA Moderate or High-Risk RET Mutations Do Not Predict Disease Aggressiveness. Conference. Medullary Thyroid Carcinoma in MEN2A: ATA Moderate or High-Risk RET Mutations Do Not Predict Disease Aggressiveness. Denver, CO, US.
- 2016. Oral Presentation: ATF4 Targets RET for Degradation and is a Candidate Tumor Suppressor Gene in Medullary Thyroid Cancer. Conference. Oral Presentation: ATF4 Targets RET for Degradation and is a Candidate Tumor Suppressor Gene in Medullary Thyroid Cancer. Denver, CO, US.
- 2016. Detection of CDKN2C and CDKN2D as Novel Prognostic Markers in Medullary Thyroid Cancer Patients. Conference. Detection of CDKN2C and CDKN2D as Novel Prognostic Markers in Medullary Thyroid Cancer Patients. Orange County, CA, US.
- 2016. Creating a Registry: Do’s and Don’t’s. Conference. American College of Surgeons. Baltimore, MD, US.
- 2016. Presentation: All in the Family? Analyzing the Impact of Family History on Medullary Thyroid Cancer Aggressiveness in MEN2A Patients. Conference. Presentation: All in the Family? Analyzing the Impact of Family History on Medullary Thyroid Cancer Aggressiveness in MEN2A Patients. Baltimore, MD, US.
- 2016. Significance of Multifocality of Sporadic Medullary Thyroid Carcinoma (MTC). Conference. Significance of Multifocality of Sporadic Medullary Thyroid Carcinoma (MTC). Boston, MA, US.
- 2016. Reevaluating the significance of multifocality in sporadic medullary thyroid carcinoma. Conference. To be printed in Annals of Surgical Oncology in November 2016. Boston, MA, US.
- 2016. Frequency of TERT Promoter Mutations in Thyroid Carcinoma Metastases. Conference. Frequency of TERT Promoter Mutations in Thyroid Carcinoma Metastases. Boston, MA, US.
- 2016. Evaluating the Significance of Multifocality in Sporadic Medullary Thyroid Carcinoma. Conference. Evaluating the Significance of Multifocality in Sporadic Medullary Thyroid Carcinoma. Boston, MA, US.
- 2015. Accuracy of data collected in a hereditary cancer registry, the MEN2 experience. Conference. Accuracy of data collected in a hereditary cancer registry, the MEN2 experience. Las Vegas, NV, US.
- 2014. Update on MEN2 Registry and RET Fusion in MTC. Conference. Update on MEN2 Registry and RET Fusion in MTC. Atlanta, GA, US.
- 2014. Genetic Predictors of Outcome in MTC. Conference. Genetic Predictors of Outcome in MTC. Boston, MA, US.
- 2013. Impact and Timing of Bilateral Adrenalectomy for Refractory ACTH-Dependent Cushing's Syndrome. Conference. Impact and Timing of Bilateral Adrenalectomy for Refractory ACTH-Dependent Cushing's Syndrome, US.
- 2012. The Biopsy-Proven Benign Thyroid Nodule:Is Long-Term Follow-Up Necessary?. Conference. The Biopsy-Proven Benign Thyroid Nodule:Is Long-Term Follow-Up Necessary?. Colorado Springs, CO, US.
- 2012. Ultrasonography should not guide the timing of thyroidectomy in pediatric patients diagnosed with multiple endocrine neoplasia syndrome 2A through genetic screening. Conference. Ultrasonography should not guide the timing of thyroidectomy in pediatric patients diagnosed with multiple endocrine neoplasia syndrome 2A through genetic screening. Orlando, FL, US.
- 2010. Longterm Outcomes of Planned Cortex Preservation in Patients requiring Bilateral Adrenalectomy for Hereditary Pheochromocytoma. Conference. Longterm Outcomes of Planned Cortex Preservation in Patients requiring Bilateral Adrenalectomy for Hereditary Pheochromocytoma. Tucson, AZ, US.
- 2010. What patients need to know. Conference. What patients need to know. Houston, TX, US.
- 2010. Selection of patient for Robotic Thyroidectomy. Conference. Selection of patient for Robotic Thyroidectomy. Houston, TX, US.
- 2010. Do the recent American Thyroid Association Guidelines accurately guide the timing of prophylactic thyroidectomy in MEN2A?. Conference. Do the recent American Thyroid Association Guidelines accurately guide the timing of prophylactic thyroidectomy in MEN2A?. Pittsburg, PA, US.
- 2009. Routine Preoperative Ultrasound for Papillary Thyroid Cancer: Long-Term Results in 236 Patients. Conference. Routine Preoperative Ultrasound for Papillary Thyroid Cancer: Long-Term Results in 236 Patients. Madison, WI, US.
- 2009. Recurrence of Adrenocortical Carcinoma Following Resection: Surgery Alone can Achieve Results Equal to Surgery Plus Mitotane. Conference. Recurrence of Adrenocortical Carcinoma Following Resection: Surgery Alone can Achieve Results Equal to Surgery Plus Mitotane. Phoenix, AZ, US.
- 2008. SPEC/CT is useful in planning incision site for minimally invasive parathyroidectomies (MIP) in treatment of primary hyperthyroidism (PHPT). Conference. SPEC/CT is useful in planning incision site for minimally invasive parathyroidectomies (MIP) in treatment of primary hyperthyroidism (PHPT). Marseille, France, US.
- 2008. Preoperative Vitamin D (VitD) Replacement Therapy in Primary Hyperparathyroidism (PHPT): Safe but Beneficial?. Conference. Preoperative Vitamin D (VitD) Replacement Therapy in Primary Hyperparathyroidism (PHPT): Safe but Beneficial?. Monterey, CA, US.
- 2008. Parathyroidectomy Improves Functional Capacity in Geriatric Patients (pts) with Seemingly "Asymptomatic" Primary Hyperparathyroidism. Conference. Parathyroidectomy Improves Functional Capacity in Geriatric Patients (pts) with Seemingly "Asymptomatic" Primary Hyperparathyroidism. Chicago, IL, US.
- 2008. A Negative Preoperative Ultrasound May Be Helpful In Planning A Minimally Invasive Parathyroidectomy. Conference. A Negative Preoperative Ultrasound May Be Helpful In Planning A Minimally Invasive Parathyroidectomy. Huntington Beach, CA, US.
- 2003. Utilizing Quantitative Polymerase Chain reaction to Evaluate Prostate Stem Cell Antigen as a Tumor Marker in Pancreatic Cancer. Conference. Utilizing Quantitative Polymerase Chain reaction to Evaluate Prostate Stem Cell Antigen as a Tumor Marker in Pancreatic Cancer. Los Angeles, CA, US.
International Presentations
- 2025. Dynamic risk stratification, indications for completion thyroidectomy & RAI. Invited. 17th International Thyroid Congress. Rio de Janeiro, BR.
- 2025. A critical review of the 2015 ATA Risk Stratification of RET mutations and timing for prophylactic thyroidectomy. Invited. 19th World MEN International Workshop on Multiple Endocrine Neoplasia and Other Rare Endocrine Tumors. São Paulo, BR.
- 2018. Surgical Management in Medullary Thyroid Cancer. Invited. New Frontiers in Cancer Treatment. Rome, IT.
- 2014. Selective parafibromin immunostaining is an effective tool in evaluating young non-MEN1 patients with primary hyperparathyroidism for CDC73 mutations. Conference. Selective parafibromin immunostaining is an effective tool in evaluating young non-MEN1 patients with primary hyperparathyroidism for CDC73 mutations. Vienna, AT.
- 2011. Cosyntropin evaluation aids in determining the need for post adrenalectomy steroid replacement. Conference. Cosyntropin evaluation aids in determining the need for post adrenalectomy steroid replacement. Yokohama, JP.
- 2009. Comparison of adrenal cortical carcinoma (ACC) staging systems by combined large database analysis. Conference. Comparison of adrenal cortical carcinoma (ACC) staging systems by combined large database analysis. Adelaide, AU.
- 2009. Mitotane for treatment of advanced adrenal cortical carcinoma (ACC): relationship of drug level and length of treatment to disease progression. Conference. Mitotane for treatment of advanced adrenal cortical carcinoma (ACC): relationship of drug level and length of treatment to disease progression. Adelaide, AU.
- 2008. Gamma Probe Identification of Normal Parathyroid Glands During Central Neck Surgery Can Facilitate Parathyroid Preservation. Conference. Gamma Probe Identification of Normal Parathyroid Glands During Central Neck Surgery Can Facilitate Parathyroid Preservation. Acapulco, MX.
- 2003. Pharmacokinetics and Drug Resistance of Alkylating Agents in Melanoma. Conference. Pharmacokinetics and Drug Resistance of Alkylating Agents in Melanoma. Montreal, CA.
- 1998. Nitric oxide synthase activity in fetal guinea pig brain following hypoxia and magnesium sulfate exposure. Conference. Nitric oxide synthase activity in fetal guinea pig brain following hypoxia and magnesium sulfate exposure. Vancouver, CA.
Formal Peers
- 2022. Faculty at Endocrine Surgery University, US.
- 2020. MTC-MEN2 Clinic. Invited. Bethesda, MD, US.
- 2018. The University of Texas Medical Branch Visiting Professor Grand Rounds. Invited. Galveston, TX, US.
- 2017. Extent of Surgery for Differentiated Thyroid Cancer: Thyroidectomy and Lymphadenectomy. Invited. Milwaukee, WI, US.
- 2017. Case Presentations: Adrenal and Parathyroid. Invited. Milwaukee, WI, US.
- 2016. Extent of Surgery for Differentiated Thyroid Cancer, Case Presentations. Invited. Green Bay, WI, US.
- 2015. Medullary Thyroid Cancer. Invited. Milwaukee, WI, US.
- 2015. Medullary Thyroid Cancer: Observations from a Rare Disease. Invited. Chicago, IL, US.
- 2014. MEN2 Consortium. Invited. Atlanta, GA, US.
- 2014. Medullary Thyroid Cancer: The MTC Registry, Why It’s Important, and What It Means for Research and Future Treatment Advances. Invited. Denver, CO, US.
- 2014. Management of adrenocortical carcinoma. Invited. Durham, NC, US.
- 2014. Surgical Treatment of Primary Hyperthyroidism. Invited. Milwaukee, WI, US.
- 2013. How Should Microcarcinomas be Handled in the Operating Room during the early riser symposium entitled Ongoing Controversies in the Surgical Management of Thyroid Cancer, 83rd Annual Meeting. Invited. San Juan, PR.
- 2013. Medullary Thyroid Cancer, 2nd World Congress on Thyroid Cancer. Invited. Toronto, CA.
- 2013. Clinical and genetic predictors of outcome in MTC and update on the MEN2 Registry. Invited. Milwaukee, IL, US.
- 2012. How is Research Evaluated?. Invited. Atlanta, GA, US.
- 2010. Controversies involving elective neck dissections in well differentiated thyroid cancer. Invited. Madison, WI, US.
Grant & Contract Support
| Date: | 2024 - 2026 |
| Title: | Cultural Adaptation of a Medullary thyroid Cancer Education Tool |
| Funding Source: | American Thyroid Association |
| Role: | PI |
| Date: | 2020 - 2025 |
| Title: | Development of the Thyroid Cancer Quality of Life Index |
| Funding Source: | American Cancer Society (ACS) |
| Role: | CO-I |
| ID: | 134591-RSG-20-024-01-CPHPS |
| Date: | 2019 - 2023 |
| Title: | A novel natural history study of medullary thyroid carcinoma: Incorporating the patient perspective to inform advanced disease management |
| Funding Source: | Food and Drug Administration (FDA) |
| Role: | PI |
| ID: | R01FD006650-01 |
| Date: | 2019 - 2021 |
| Title: | Advanced Medullary Thyroid Cancer: Patient Decision Aid Development & Usability Test |
| Funding Source: | The University of Texas MD Anderson Cancer Center Institutional Research Grant |
| Role: | PI |
| Date: | 2018 - 2026 |
| Title: | Genetics of Endocrine Neoplasia Registry |
| Funding Source: | Loxo Oncology Inc |
| Role: | PI |
| Date: | 2018 - 2026 |
| Title: | Genetics of Endocrine Neoplasia Registry |
| Funding Source: | Exelixis, Inc |
| Role: | PI |
| Date: | 2014 - 2016 |
| Title: | Fusion Oncogenes as Drivers of Medullary Thyroid Cancer |
| Funding Source: | The American Thyroid Association (ATA) |
| Role: | PI |
| Date: | 2013 - 2018 |
| Title: | The Ohio State University and MD Anderson Cancer Center Thyroid Cancer SPORE |
| Funding Source: | NIH/NCI |
| Role: | CO-I |
| ID: | P50 CA168505 |
| Date: | 2013 - 2015 |
| Title: | Aberrant CDK Pathway Contribution to the Aggressiveness of Medullary Thyroid Carcinoma |
| Funding Source: | NIH/NCI |
| Role: | Co-PI |
| ID: | P50 CA168505 The Ohio State University and MD Anderson Cancer Center Thyroid Cancer SPORE |
| Date: | 2012 - 2013 |
| Title: | Molecular characterization of unusual responders with MTC to Tyrosine Kinase Inhibitors |
| Funding Source: | Institute of Personalized Cancer Therapy Unusual Responder Program |
| Role: | Co-PI |
| Date: | 2011 - 2017 |
| Title: | Identifying key factors affecting the clinical course of MEN2 thyroid cancer |
| Funding Source: | American Cancer Society (ACS), Mentored Scholar Research Grant |
| Role: | PI |
| ID: | MRSGM-11-12-01-CCE |
| Date: | 2010 - 2011 |
| Title: | Identification of novel genetic predictors of outcome in sporadic and MEN-related medullary thyroid carcinoma |
| Funding Source: | MD Anderson Head and Neck SPORE Career Development Award |
| Role: | PI |
| ID: | G5 PA50 CA09707 08 |
Selected Publications
Peer-Reviewed Articles
- Allen DZ, Hosseini SM, Zafereo M, Lango M, Grubbs EG, Iyer P, Patel SR, Ravi V, Busaidy NL, Wang RJ, Williams MD, Cabanillas ME, Maniakas A. Deceptive Thyroid Pathologies: Anaplastic Thyroid Carcinoma Mimics and Clinical Implications. Head Neck, 2026. e-Pub 2026. PMID: 41834435.
- Tame-Elorduy, A, Druar, N, Tibbels, A, Shariq, O, Landry, JP, Onuma, AE, Ying, AK, Chiang, YJ, Graham, PH, Fisher, SB, Grubbs, EG, Perrier, ND. Predictive value of preoperative TSH levels for thyroid hormone supplementation post-thyroid lobectomy. Surgical Oncology Insight 3(1), 2026. e-Pub 2026.
- Cunningham CE, van Dijk S, Langer MM, Moronta S, Herman T, Collins RA, Digennaro C, Galvan AK, Varghese JM, Lango M, Jalali M, Fisher S, Grubbs EG, Donelan K, Swan JS. A Thyroid-Cancer-Specific Utility Index: Development and Valuation of the Thyroid Cancer Quality of Life Index. Thyroid 36(3):278-290, 2026. e-Pub 2026. PMID: 41735804.
- Onuma AE, Skefos CM, Richardson ME, Pasyar S, Fergus KB, Bassett RL, Hu MI, Perrier ND, Maniakas A, Zafereo M, Waguespack SG, Sosa JA, Grubbs EG. The shifting landscape of germline RET pathogenic variants with the introduction of panel testing. Surgery 189:109701, 2026. e-Pub 2026. PMID: 41371824.
- Ringel MD, Sosa JA, Baloch Z, Bischoff L, Bloom G, Brent GA, Brock PL, Chou R, Flavell RR, Goldner W, Grubbs EG, Haymart M, Larson SM, Leung AM, Osborne JR, Ridge JA, Robinson B, Steward DL, Tufano RP, Wirth LJ. 2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer. Thyroid 35(8):841-985, 2025. e-Pub 2025. PMID: 40844370.
- Forrest D, Sipos JA, Grubbs EG. Summary of the Year in Review Lectures at the 2024 Annual Meeting of the American Thyroid Association. Thyroid 35(2):123-130, 2025. e-Pub 2025. PMID: 39873525.
- Hamidi S, Yedururi S, Hu MI, Busaidy NL, Sherman SI, Jimenez C, Grubbs EG, Maniakas A, Zafereo ME, Subbiah V, Waguespack SG. Efficacy and Safety of Selective RET Inhibitors in Patients with Advanced Hereditary Medullary Thyroid Carcinoma. Thyroid 35(1):6-17, 2025. e-Pub 2025. PMID: 39630530.
- Szabo, YT, Tame-Elorduy A, Skefos, SM, Varghese, JM, Habra, MA, Fisher, SB, Graham, PH, Grubbs EG, Waguespack, SG, Jimenez, C, Perrier, ND. SDHB-Associated Pheochromocytomas: What is Their Clinical Behavior?. Ann Surg Oncol 31(3):9007-9013, 2024. e-Pub 2024. PMID: 39382746.
- Grubbs EG, Lillemoe HA. Competency-based education across the surgery continuum. Surgery, 2024. PMID: 39488454.
- Szabo Yamashita T, Williams-Perez SM, Ehsan S, Mulder M, Kronenfeld D, Huang CY, Zhao H, Merriman K, Peterson SK, Hu MI, Zafereo M, Sosa JA, Grubbs EG. The Multi-Institutional Medullary Thyroid Cancer Collaborative Registry: Can a Rare Tumor Registry Accurately Represent the Real-World Patient Population?. Thyroid 34(9):1117-1125, 2024. e-Pub 2024. PMID: 38984944.
- Hensley SG, Hu MI, Bassett RL, Ying AK, Zafereo ME, Perrier ND, Busaidy NL, Hyde SM, Grubbs EG, Waguespack SG. Pediatric Medullary Thyroid Carcinoma: Clinical Presentations and Long-Term Outcomes in 144 Patients Over 6 Decades. J Clin Endocrinol Metab 13(109):2256-2268, 2024. e-Pub 2024. PMID: 38441533.
- Shirali AS, Hu MI, Chiang YJ, Graham PH, Fisher SB, Sosa JA, Brown S, Holla VR, Dadu R, Busaidy N, Sherman SI, Cabanillas M, Waguespack SG, Zafereo ME, Grubbs EG. Next-Generation Sequencing in Sporadic Medullary Thyroid Cancer Patients: Mutation Profile and Disease Aggressiveness. J. Endocr Soc, 2024. e-Pub 2024. PMID: 38660141.
- Dineen, SP, Behrens, S, Grubbs, EG, Davis, JL, Farma, JM. ASO Author Reflections. Annals of surgical oncology 31(3):1785-1786, 2024. e-Pub 2024. PMID: 38062295.
- Maniakas, A, Sullivan, A, Hu, MI, Busaidy, NL, Cabanillas, ME, Dadu, R, Waguespack, SG, Fisher, SB, Graham, PH, Gross, N, Grubbs, EG, Perrier, ND, Wang, RJ, Gunn, GB, Garden, AS, Megahed, R, Navuluri, S, Li, X, Williams, MD, Zafereo, M. Decreasing utilization for postoperative radiation therapy in locoregionally advanced medullary thyroid cancer. Head and Neck 46(2):328-335, 2024. e-Pub 2024. PMID: 38009416.
- Szabo Yamashita, T, Shirali, AS, Meas, S, Sarli, VN, Clemente-Gutierrez, U, Chiang, YJ, Silva-Figueroa, A, Vodopivec, DM, Williams, MD, Fisher, SB, Graham, PH, Grubbs, EG, Lucci, A, Busaidy, NL, Perrier, ND. Is there a role for liquid biopsy in the surveillance of parathyroid carcinoma?. Surgery (United States) 175(1):193-198, 2024. e-Pub 2024. PMID: 37993289.
- Behrens, S, Lillemoe, HA, Dineen, SP, Russell, MC, Visser, BC, Berman, RS, Farma, JM, Grubbs, EG, Davis, JL. Perceptions of Readiness for Practice After Complex General Surgical Oncology Fellowship. Annals of surgical oncology 31(1):31-41, 2024. e-Pub 2024. PMID: 37936022.
- Clemente-Gutierrez, U, Pieterman, CR, Lui, MS, Yamashita, TS, Tame-Elorduy, A, Huang, BL, Shirali, AS, Erstad, DJ, Lee, JE, Fisher, SB, Graham, PH, Grubbs, EG, Waguespack, SG, Ng, CS, Perrier, ND. Beyond the three P’s. Endocrine-related cancer 31(2), 2024. e-Pub 2024. PMID: 38108666.
- Lui MS, Clemente-Gutierrez U, Vodopivec DM, Chang SL, Shirali AS, Huang BL, Chiang YJ, Fisher SB, Grubbs EG, Guise TA, Graham PH, Perrier ND. Parathyroidectomy for Normocalcemic Primary Hyperparathyroidism is Associated with Improved Bone Mineral Density Regardless of Postoperative Parathyroid Hormone Levels. World J Surg 47(2):363-370, 2023. e-Pub 2023. PMID: 36195677.
- Contrera KJ, Gule-Monroe M, Hu MI, Cabanillas M, Busaidy N, Dadu R, Waguespack SG, Wang JR, Maniakas A, Lai SY, Diersing J, Kwon M, Grubbs EG, Subbiah V, Williams MD, Zafereo ME. Neoadjuvant Selective RET Inhibitor for Medullary Thyroid Cancer: A Case Series. Thyroid 33(1):129-132, 2023. e-Pub 2023. PMID: 36503246.
- Shirali AS, Clemente-Gutierrez U, Huang BL, Lui MS, Chiang YJ, Jimenez C, Fisher SB, Graham PH, Lee JE, Grubbs EG, Perrier ND. Pheochromocytoma recurrence in hereditary disease: does a cortical-sparing technique increase recurrence rate?. Surgery 1(173):26-34, 2023. e-Pub 2023. PMID: 36229248.
- Shirali AS, Zagzag J, Chiang YJ, Huang H, Zhang M, Habra MA, Grubbs EG, Fisher SB, Perrier ND, Lee JE, Graham PH. Differences in Clinicopathologic Behavior of Oncocytic Adrenocortical Neoplasms and Conventional Adrenocortical Carcinomas. Ann Surg Oncol 29(9):5555-5563, 2022. e-Pub 2022. PMID: 35499784.
- Landry JP, Pieterman CRC, Clemente-Gutierrez U, Grubbs EG, Fisher SB, Graham PH, Waguespack SG, Perrier ND. Evaluation of risk factors, long-term outcomes, and immediate and delayed autotransplantation to minimize postsurgical hypoparathyroidism in multiple endocrine neoplasia type 1 (MEN1): A retrospective cohort study. Surgery 171(5):1240-1246, 2022. e-Pub 2022. PMID: 34952716.
- DiPeri TP, Newhook TE, Day RW, Chiang YJ, Dewhurst WL, Arvide EM, Bruno ML, Scally CP, Roland CL, Katz MHG, Vauthey JN, Chang GJ, Badgwell BD, Perrier ND, Grubbs EG, Lee JE, Tzeng CD. A prospective feasibility study evaluating the 5x-multiplier to standardize discharge prescriptions in cancer surgery patients. Surg Open Sci 9:51-57, 2022. e-Pub 2022. PMID: 35663797.
- Beninato T, Laird AM, Graves CE, Drake FT, Alhefdhi A, Lee JA, Kuo JH, Grubbs EG, Wang TS, Pasieka JL, Lubitz CC. Impact of the COVID-19 pandemic on the practice of endocrine surgery. Am J Surg 223(4):670-675, 2022. e-Pub 2022. PMID: 34315576.
- Nofal S, You YN, Chang GJ, Grubbs EG, Bednarski B. Development of an Online Curriculum for Surgeons on the Use of Pelvic Magnetic Resonance Imaging in Rectal Cancer and Results of a Pilot Study. J Surg Res(270):279-785, 2022. e-Pub 2022. PMID: 34717261.
- Shirali AS, Wu SY, Chiang YJ, Graham PH, Grubbs EG, Lee JE, Perrier ND, Fisher SB. Recurrence after successful parathyroidectomy-Who should we worry about?. Surgery 171(1):40-46, 2022. e-Pub 2022. PMID: 34340820.
- Chick RC, Adams AM, Peace KM, Kemp Bohan PM, Schwantes IR, Clifton GT, Vicente D, Propper B, Newhook T, Grubbs EG, Bednarski BK, Vreeland TJ. Using the Flipped Classroom Model in Surgical Education: Efficacy and Trainee Perception. J Surg Educ 78(6):1803-1807, 2021. e-Pub 2021. PMID: 34210646.
- Shojaie D, Hoffman AS, Amaku R, Cabanillas ME, Sosa JA, Waguespack SG, Zafereo ME, Hu MI, Grubbs EE. Decision Making When Cancer Becomes Chronic: Needs Assessment for a Web-Based Medullary Thyroid Carcinoma Patient Decision Aid. JMIR Form Res 5(7):e27484, 2021. e-Pub 2021. PMID: 34269691.
- Hill MV, Ross EA, Crawford D, Lai L, Turaga K, Grubbs EG, Mullen J, Dineen S, D'Angelica M, Reddy S, Farma JM. Program and candidate experience with virtual interviews for the 2020 Complex General Surgical Oncology interview season during the COVID pandemic. Am J Surg 222(1):99-103, 2021. e-Pub 2021. PMID: 33189309.
- Lee TC, McKinley SK, Dream SY, Grubbs EG, Dissanaike S, Fong Z. Pearls and Pitfalls of the Virtual Interview: Perspectives from Both Sides of the Camera. J Surg Res(262):240-243, 2021. e-Pub 2021. PMID: 33549329.
- Williams MD, Ma J, Grubbs EG, Gagel RF, Bagheri-Yarmand R. ATF4 loss of heterozygosity is associated with poor overall survival in medullary thyroid carcinoma. Am J Cancer Res 11(6):3227-3239, 2021. e-Pub 2021. PMID: 34249457.
- Lubitz CC, Kiernan CM, Toumi A, Zhan T, Roth MY, Sosa JA, Tuttle RM, Grubbs EG. Patient Perspectives on the Extent of Surgery and Radioactive Iodine Treatment for Low-Risk Differentiated Thyroid Cancer. Endocr Pract 27(5):383-389, 2021. e-Pub 2021. PMID: 33840638.
- Pieterman CRC, Hyde SM, Wu SY, Landry JP, Chiang YJ, Christakis I, Grubbs EG, Fisher SB, Graham PH, Waguespack SG, Perrier ND. Understanding the clinical course of genotype-negative MEN1 patients can inform management strategies. Surgery 169(1):175-184, 2021. e-Pub 2021. PMID: 32703679.
- Jozaghi Y, Zafereo M, Williams MD, Gule-Monroe MK, Wang J, Grubbs EG, Vaporciyan A, Hu MI, Busaidy N, Dadu R, Waguespack SG, Subbiah V, Cabanillas M. Neoadjuvant selpercatinib for advanced medullary thyroid cancer. Head Neck 43(1):E7-E12, 2021. e-Pub 2021. PMID: 33169506.
- Chang K, Berthelet E, Grubbs E, Hamilton S, Karvat A, Tran E, Wu J, Ingledew PA. Websites, Websites Everywhere: How Thyroid Cancer Patients Use the Internet. J Cancer Educ 35(6):1177-1183, 2020. e-Pub 2020. PMID: 31332622.
- Lillemoe HA, Newhook TE, Aloia TA, Grubbs EG, Chang GJ, Katz MHG, Vauthey JN, Lee JE, Tzeng CD. Perceptions of opioid use and prescribing habits in oncologic surgery: A survey of the society of surgical oncology membership. J Surg Oncol 122(6):1066-1073, 2020. e-Pub 2020. PMID: 32632993.
- Hill MV, Ross EA, Crawford D, Lai L, Turaga K, Grubbs EG, Mullen J, Dineen S, D'Angelica M, Reddy S, Farma JM. Program and candidate experience with virtual interviews for the 2020 Complex General Surgical Oncology interview season during the COVID pandemic. Am J Surg 10(20):30730-3, 2020. e-Pub 2020. PMID: 33189309.
- Hegde A, Andreev-Drakhlin AY, Roszik J, Huang L, Liu S, Hess K, Cabanillas M, Hu MI, Busaidy NL, Sherman SI, Dadu R, Grubbs EG, Ali SM, Lee J, Elamin YY, Simon GR, Jr BG, Papadimitrakopoulou VA, Hong D, Meric-Bernstam F, Heymach J, Subbiah V. Responsiveness to immune checkpoint inhibitors versus other systemic therapies in RET-aberrant malignancies. ESMO Open 5(5):e000799, 2020. e-Pub 2020. PMID: 33097651.
- Dalwadi SM, Dorman C, Fisher SB, Bonnen M, Grubbs E, Ludwig MS. Risk of thyroid cancer after therapeutic irradiation in adult patients: An Age-Based surveillance, epidemiology, and end results analysis. Laryngoscope 130(8):2081-2086, 2020. e-Pub 2020. PMID: 31747075.
- Carter, AM, Tan, C, Pozo, K, Tekabga, Molinaro, R, Ailan, G, Rosa D, E, Martinez, JO, Zhang S, Kumar, N, Takahashi, M, Wiederhold, T, Ghayee, HK Oltmann HK, SC, Pacak, K, Woltering, EA, Hatanpaa, KJ Nwariaku KJ, FE, Grubbs, EG, Gill, AJ, Robinson, B, Gillardon, F, Reddy, S, Jaskula-Sztul, R, Mobley, JA, Mukhtar, MS Tasciotti MS, E, Chen, H, Bibb JA. Phosphoprotein-based Biomarkers as Predictors for Cancer Therapy. Proceedings of the National Academy of Sciences 117(31):18401-18411, 2020. e-Pub 2020. PMID: 32690709.
- Day RW, Taylor BM, Bednarski B, Tzeng CD, Gershenwald JE, Lee JE, Grubbs EG. Virtual Interviews for Surgical Training Program Applicants During COVID-19: Lessons Learned and Recommendations. Ann Surg 272(2):e144-e147, 2020. e-Pub 2020. PMID: 32675519.
- Altinmakas E, Perrier ND, Grubbs EG, Lee JE, Prieto VG, Ng CS. Diagnostic performance of adrenal CT in the differentiation of adenoma and pheochromocytoma. Acta Radiol 61(8):1080-1086, 2020. e-Pub 2020. PMID: 31791129.
- Grubbs, EG, Lechan, RM, Edeiken-MonroeB, Cote, GJ, Trotter, C, Tischler, AS, Gagel, RF. HEREDITARY ENDOCRINE TUMOURS: CURRENT STATE-OF-THE-ART AND RESEARCH OPPORTUNITIES: Early thyroidectomy in multiple endocrine neoplasia: a four decade experience. Endocr Relat Cancer 27(8):T1-T8, 2020. e-Pub 2020. PMID: 32464600.
- Dadu, R, B-Y R, Ringel, MD, 2, Grubbs, EG, Zafereo, M, Cote, G, Gagel RF, Robinson BG, Kenna RS, Hu MI. HEREDITARY ENDOCRINE TUMOURS: CURRENT STATE-OF-THE-ART AND RESEARCH OPPORTUNITIES: The state of science in medullary thyroid carcinoma: current challenges and unmet needs. Endocr Relat Cancer 27(8):T27-T39, 2020. e-Pub 2020. PMID: 32464600.
- Roland C, Grubbs, EG, Katz, MHG, Teshome, E, Tzeng CW. Clinical Trials - Designing, Implementing, and Collaborating. Journal of Surgical Oncology 122(1):25-28, 2020. e-Pub 2020. PMID: 32149390.
- Jozaghi Y, Zafereo ME, Perrier ND, Wang JR, Grubbs E, Gross ND, Fisher SB, Sturgis EM, Goepfert RP, Lai SY, Best C, Busaidy NL, Cabanillas ME, Dadu R, Gagel RF, Habra MA, Hu MI, Jimenez C, Sherman SI, Thosani S, Varghese J, Waguespack SG, Weitzman S, Ying AK, Graham PH. Endocrine surgery in the Coronavirus disease 2019 pandemic: Surgical Triage Guidelines. Head & Neck 42(6):1325-1328, 2020. e-Pub 2020.
- Zafereo M, McIver B, Vargas S, Domínguez Ruiz-Tagle JM, Steward D, Holsinger FC, Kandil E, Williams MD, Cruz F, Loyola S, Solar A, Roa JC, Leon A, Droppelmann N, Arias T, Lobos M, Kong CS, Busaidy N, Grubbs EG, Graham PH, Stewart J, Tang A, Wang J, Orloff LA, Hernríquez-Henríquez M, Lagos M, Wohllk N, Diaz RE, Véliz J, Horvath E, Tala H, Pineda P, Arroyo P, Vasquez F, Osorio M, Schacter D, Franco C, Medina F, Traipe E, Marin L, Miranda G, Bruce E, Bracamonte Nole M, Mena N, Gonzalez H. A Thyroid Genetic Classifier Correctly Predicts Benign Nodules with Indeterminate Cytology: Two-Independent Muliticenter, Prospective Validation Trials. Thydoid 30(5):704-712, 2020. e-Pub 2020. PMID: 31910118.
- Patel KN, Yip L, Lubitz CC, Grubbs EG, Miller BS, Shen W, Angelos P, Chen H, Doherty GM, 3rd FT, Kebebew E, Livolsi VA, Perrier ND, Sipos JA, Sosa JA, Steward D, Tufano RP, McHenry CR, Carty SE. Executive Summary of the American Association of Endocrine Surgeons Guidelines for the Definitive Surgical Management of Thyroid Disease in Adults. Ann Surg 271(3):399-410, 2020. e-Pub 2020. PMID: 32079828.
- Patel KN, Yip L, Lubitz CC, Grubbs EG, Miller BS, Shen W, Angelos P, Chen H, Doherty GM, 3rd FT, Kebebew E, Livolsi VA, Perrier ND, Sipos JA, Sosa JA, Steward D, Tufano RP, McHenry CR, Carty SE. The American Association of Endocrine Surgeons Guidelines for the Definitive Surgical Management of Thyroid Disease in Adults. Ann Surg 271(3):e21-e93, 2020. e-Pub 2020. PMID: 32079830.
- Fisher SB, Habra MA, Chiang YJ, Wu SY, Graham PH, Grubbs EG, Lee JE, Perrier ND. Comparative Performance of the 7th and 8th Editions of the American Joint Committee on Cancer Staging Manual for Adrenocortical Carcinoma. World J Surg 44(2):544-551, 2020. e-Pub 2020. PMID: 31493191.
- Nofal S, You YN, Chang GJ, Grubbs EG, Bednarski BK. Residents entering Complex General Surgical Oncology fellowship lack confidence with pelvic MRI for rectal cancer: Results of a needs assessment survey. Am J Surg 219(2):304-308, 2020. e-Pub 2020. PMID: 31753316.
- Wu SY, Chiang YJ, Fisher SB, Sturgis EM, Zafereo ME, Nguyen S, Grubbs EG, Graham PH, Lee JE, Waguespack SG, Perrier ND. Risks of Hypoparathyroidism After Total Thyroidectomy in Children: A 21-Year Experience in a High-Volume Cancer Center. World J Surg 44(2):442-451, 2020. e-Pub 2020. PMID: 31686157.
- Maxwell JE, Gule-Monroe MK, Subbiah V, Hu M, Perrier ND, Cabanillas ME, Lee JE, Graham PH, Cote GJ, Busaidy NL, Grubbs EG. Novel use of a Clinical Laboratory Improvements Amendments (CLIA)-certified Cyclin-Dependent Kinase N2C (CDKN2C) loss assay in sporadic medullary thyroid carcinoma. Surgery 167(1):80-86, 2020. e-Pub 2020. PMID: 31648931.
- Silva-Figueroa AM, Jr BR, Christakis I, Moreno P, Clarke CN, Busaidy NL, Grubbs EG, Lee JE, Perrier ND, Williams MD. Using a Novel Diagnostic Nomogram to Differentiate Malignant from Benign Parathyroid Neoplasms. Endocr Pathol 30(4):285-296, 2019. e-Pub 2019. PMID: 31734935.
- Gan Q, Edeiken BS, Chen MM, Grubbs EG, Busaidy NL, Zafereo M, Perrier ND, Gule-Monroe MD, Krishnamurthy S. Utility of subcategorization of atypia of undetermined significance/follicular lesion of undetermined significance category in ultrasound-guided thyroid fine-needle aspiration in a large referral cancer center. J Am Soc Cytopathol 8(6):309-316, 2019. e-Pub 2019. PMID: 31526696.
- Chang KL, Grubbs EG, Ingledew PA. An Analysis of the Quality of Thyroid Cancer Websites. Endocrine Pract 25(10):1003-1011, 2019. e-Pub 2019. PMID: 31170373.
- Asare EA, Silva-Figueroa A, Hess KR, Busaidy N, Graham PH, Grubbs EG, Lee JE, Williams MD, Perrier ND. Risk of Distant Metastasis in Parathyroid Carcinoma and Its Effect on Survival: A Retrospective Review from a High-Volume Center. Ann Surg Oncol 26(11):3593-3599, 2019. e-Pub 2019. PMID: 31111352.
- Lillemoe HA, Scally CP, Adams CL, Bednarski BK, Balch CM, Aloia TA, Gershenwald JE, Lee JE, Grubbs EG. Complex General Surgical Oncology Fellowship Applicants: Trends over Time and the Impact of Board Certification Eligibility. Ann Surg Oncol 26(9):2669-2674, 2019. e-Pub 2019. PMID: 31168736.
- Wach MM, Ayabe RI, Ruff SM, D'Angelica M, Dineen SP, Grubbs EG, Shibata D, Shirley L, Weiss MJ, Davis JL, Hernandez JM. A Survey of the Complex General Surgical Oncology Fellowship Programs Regarding Applicant Selection and Rank. Ann Surg Oncol 26(9):2675-26981, 2019. e-Pub 2019. PMID: 31011903.
- Kiernan CM, Grubbs EG. Surgical Management of Multiple Endocrine Neoplasia 1 and Multiple Endocrine Neoplasia 2. Surg Clin North Am 99(4):693-709, 2019. e-Pub 2019. PMID: 31255200.
- Lillemoe HA, Newhook TE, Vreeland TJ, Arvide EM, Dewhurst WL, Grubbs EG, Aloia TA, Vauthey JN, Lee JE, Tzeng CD. Educating Surgical Oncology Providers on Perioperative Opioid Use: Results of a Departmental Survey on Perceptions of Opioid Needs and Prescribing Habits. Ann Surg Oncol 26(7):2011-2018, 2019. e-Pub 2019. PMID: 30937660.
- Asare EA, Grubbs EG, Gershenwald JE, Greene FL, Aloia TA. Setting the "stage" for Surgical Oncology fellows: Pierre Denoix and TNM staging. J Surg Oncol 119(7):823, 2019. e-Pub 2019. PMID: 30729519.
- Kiernan CM, Wang T, Perrier ND, Grubbs EG, Solórzano CC. Bilateral Neck Exploration for Sporadic Primary Hyperparathyroidism: Utilization Patterns in 5,597 Patients Undergoing Parathyroidectomy in the Collaborative Endocrine Surgery Quality Improvement Program. J Am Coll Surg 288(4):652-659, 2019. e-Pub 2019. PMID: 30677525.
- Christakis I, Ng CS, Chen C, Yiin YH, Grubbs EG, Perrier ND, Lee JE, Graham PH. Operation duration and adrenal gland size, but not BMI, are correlated with complication rate for posterior retroperitoneoscopic adrenalectomy for benign diseases. Surgery 165(6):637-643, 2019. e-Pub 2019. PMID: 30482519.
- Castinetti F, Waguespack SG, Machens A, Uchino S, Lazaar K, Sanso G, Else T, Dvorakova S, Qi XP, Elisei R, Maia AL, Glod J, Jr LD, Valdes N, Mathiesen J, Wohllk N, Bandgar TR, Drui D, Korbonits M, Druce MR, Brain C, Kurzawinski T, Patocs A, Bugalho MJ, Lacroix A, Caron P, Fainstein-Day P, Borson Chazot F, Klein M, Links TP, Letizia C, Fugazzola L, Chabre O, Canu L, Cohen R, Tabarin A, Spehar Uroic A, Maiter D, Laboureau S, Mian C, Peczkowska M, Sebag F, Brue T, Mirebeau-Prunier D, Leclerc L, Bausch B, Berdelou A, Sukurai A, Vlcek P, Krajewska J, Barontini M, Vaz Ferreira Vargas C, Valerio L, Ceolin L, Akshintala S, Hoff A, Godballe C, Jarzab B, Jimenez C, Eng C, Imai T, Schlumberger M, Grubbs E, Dralle H, Neumann HP, Baudin E. Natural history, treatment, and long-term follow up of patients with multiple endocrine neoplasia type 2B: an international, multicentre, retrospective study. Diabetes & Endocrinology 7(3):213-220, 2019. e-Pub 2019. PMID: 30660595.
- Fisher SB, Cote GJ, Bui-Griffith JH, Lu W, Tang X, Hai T, Fisher KE, Williams MD, Wistuba II, Waguespack SG, Dorman CM, Ludwig MS, Graham PH, Perrier ND, Lee JE, Grubbs EG. Genetic characterization of medullary thyroid cancer in childhood survivors of the Chernobyl accident. Surgery 165(1):58-63, 2019. e-Pub 2019. PMID: 30392857.
- Pozo K, Zahler S, Ishimatsu K, Carter AM, Telange R, Tan C, Wang S, Pfragner R, Fujimoto J, Grubbs EG, Takahashi M, Oltmann SC, Bibb JA. Preclinical characterization of tyrosine kinase inhibitor-based targeted therapies for neuroendocrine thyroid cancer. Oncotarget 9(102):37662-37675, 2018. e-Pub 2018. PMID: 30701022.
- Dickson PV, Kim L, Yen TWF, Yang A, Grubbs EG, Patel D, Solórzano CC. Adjuvant and Neoadjuvant Therapy, Treatment for Advanced Disease, and Genetic Considerations for Adrenocortical Carcinoma: An Update from the SSO Endocrine and Head and Neck Disease Site Working Group. Ann Surg Oncol 25(12):3453-3459, 2018. e-Pub 2018. PMID: 30218246.
- Dickson PV, Kim L, Yen TWF, Yang A, Grubbs EG, Patel D, Solórzano CC. Evaluation, Staging, and Surgical Management for Adrenocortical Carcinoma: An Update from the SSO Endocrine and Head and Neck Disease Site Working Group. Ann Surg Oncol 25(12):3460-3468, 2018. e-Pub 2018. PMID: 30229419.
- Hughes DT, Rosen JE, Evans DB, Grubbs E, Wang TS, Solórzano CC. Prophylactic Central Compartment Neck Dissection in Papillary Thyroid Cancer and Effect on Locoregional Recurrence. Ann Surg Oncol 25(9):2526-2534, 2018. e-Pub 2018. PMID: 29786126.
- Tam S, Amit M, Boonsripitayanon M, Busaidy N, Cabanillas M, Waguespack SG, Gross ND, Grubbs EG, Williams MD, Lai SY, Sturgis E, Zafereo M. Effect of Tumor Size and Minimal Extrathyroidal Extension in Patients with Differentiated Thyroid Cancer. Thyroid 28(8):982-990, 2018. e-Pub 2018. PMID: 29936892.
- Ng CS, Altinmakas E, Wei W, Ghosh P, Li X, Grubbs EG, Perrier NA, Prieto VG, Lee JE, Hobbs BP. Combining Washout and Noncontrast Data from Adrenal Protocol CT: Improving Diagnostic Performance. Acad Radiol 25(7):861-868, 2018. e-Pub 2018. PMID: 29398440.
- Ng CS, Altinmakas E, Wei W, Ghosh P, Li X, Grubbs EG, Perrier ND, Lee JE, Prieto VG, Hobbs BP. Utility of Intermediate-Delay Washout CT Images for Differentiation of Malignant and Benign Adrenal Lesions: A Multivariate Analysis. AJR Am J Roentgenol 211(2):W109-W115, 2018. e-Pub 2018. PMID: 29949418.
- Romero Arenas MA, Rich TA, Hyde SM, Busaidy NL, Cote GJ, Hu MI, Gagel RF, Gidley PW, Jimenez C, Kupferman ME, Peterson SK, Sherman SI, Ying A, Jr BR, Waguespack SG, Perrier ND, Grubbs EG. Recontacting Patients with Updated Genetic Testing Recommendations for Medullary Thyroid Carcinoma and Pheochromocytoma or Paraganglioma. Ann Surg Oncol 25(5):1395-1402, 2018. e-Pub 2018. PMID: 29427212.
- Ng CS, Wei W, Altinmakas E, Li X, Ghosh P, Perrier NA, Grubbs E, Prieto VG, Lee JE, Hobbs BP. Differentiation of Malignant and Benign Adrenal Lesions With Delayed CT: Multivariate Analysis and Predictive Models. AJR Am J Roentgenol 04(2018):W156-W163, 2018. e-Pub 2018. PMID: 29412015.
- Jaber T, Hyde SM, Cote GJ, Grubbs EG, Giles WH, Stevens CA, Dadu R. A homozygous RET K666N genotype with an MEN2A phenotype. J Clin Endocrinol Metab 103(4):1269-1272, 2018. e-Pub 2018. PMID: 29408964.
- Romero Arenas MA, Whitsett TG, Aronova A, Henderson SA, LoBello J, Habra MA, Grubbs EG, Lee JE, Sircar K, Zarnegar R, Scognamiglio T, Fahey TJ, Perrier ND, Demeure MJ. Protein Expression of PTTG1 as a Diagnostic Biomarker in Adrenocortical Carcinoma. Ann Surg Oncol 25(3):801-807, 2018. e-Pub 2018. PMID: 29218429.
- Amit M, Tam S, Boonsripitayanon M, Cabanillas ME, Busaidy NL, Grubbs EG, Lai SY, Gross ND, Sturgis EM, Zafereo ME. Association of Lymph Node Density With Survival of Patients With Papillary Thyroid Cancer. JAMA Otolaryngol Head Neck Surg 144(2):108-114, 2018. e-Pub 2018. PMID: 29192312.
- Christakis I, Qiu W, Hyde SM, Cote GJ, Grubbs EG, Perrier ND, Lee JE. Genotype-phenotype pancreatic neuroendocrine tumor relationship in multiple endocrine neoplasia type 1 patients: A 23-year experience at a single institution. Surgery 161(1):212-217, 2018. e-Pub 2018. PMID: 29122330.
- Pena I, Clayman GL, Grubbs EG, Jr BJ, Waguespack SG, Cabanillas ME, Dadu R, Hu MI, Fellman BM, Li Y, Gross ND, Lai SY, Sturgis EM, Zafereo ME. Management of the Lateral Neck Compartment in Patients with Sporadic Medullary Thyroid Cancer. Head Neck 40(1):79-85, 2018. e-Pub 2018. PMID: 29044788.
- Valenciaga A, Grubbs EG, Porter K, Jr WP, Williams MD, Cote GJ, Vasko VV, Saji M, Ringel MD. Reduced Retinoblastoma Protein Expression Is Associated with Decreased Patient Survival in Medullary Thyroid Cancer. Thyroid 27(12):1523-1533, 2017. e-Pub 2017. PMID: 29105562.
- Christakis I, Silva AM, Williams MD, Garden A, Grubbs EG, Busaidy NL, Lee JE, Perrier ND, Zafereo M. Postoperative local-regional radiation therapy in the treatment of parathyroid carcinoma: The MD Anderson experience of 35 years. Pract Radiat Oncol 7(6):e463-e470, 2017. e-Pub 2017. PMID: 28751227.
- Cote, GJ, Evers, C, Hu, MI, Grubbs EG, Williams, MD, Hai, T, Duose, DY, Houston, MR, Bui, JH, Mehrotra, M, Waguespack, SG, Busaidy, NI, Cabanillas, ME, Habra, MA, Luthra R, Sherman SI. Prognostic Significance of Circulating RET M918T Mutated Tumor DNA in Patients with Advanced Medullary Thyroid Carcinoma. Journal of Clinical Endocrine & Metabolism 102(8):3591-3599, 2017. e-Pub 2017. PMID: 28911154.
- Voss RK, Grubbs EG. Response Letter: "Medullary Thyroid Carcinoma in MEN2A: ATA Moderate- or High-Risk RET Mutations Do Not Predict Disease Aggressiveness". J Clin Endocrinol Metab 102(9):3559, 2017. e-Pub 2017. PMID: 28911160.
- ME Naofal ME, A Kim A, HY Yon HY, M Baity M, Z Ming Z, J Bui-Griffith J, Z Tang Z, M Robinson M, Grubbs EG, Cote G, P Hu P. Role of CDKN2C Fluorescence In Situ Hybridization in the Management of Medullary Thyroid Carcinoma. Annals of Clinical & Laboratory Science 47(5):523-528, 2017. e-Pub 2017. PMID: 29066476.
- Voss RK, Feng L, Lee JE, Perrier ND, Graham PH, Hyde SM, Nieves-Munoz F, Cabanillas ME, Waguespack SG, Cote GJ, Gagel RF, Grubbs EG. Medullary Thyroid Carcinoma in MEN2A: ATA Moderate or High-Risk RET Mutations Do Not Predict Disease Aggressiveness. J Clinic Endocrinol Metab 102(8):2807-2813, 2017. e-Pub 2017. PMID: 28609830.
- Hyde, SM, Cote, GJ, Grubbs EG. Genetics of Multiple Endocrine Neoplasia Type 1/Multiple Endocrine Neoplasia Type 2 Syndromes. Endocrinology and Metabolism Clinics of North America 46(2):491-501, 2017. e-Pub 2017. PMID: 28476233.
- Starker LF, Christakis I, Julien JS, Schwarz K, Graham P, Grubbs EG, Lee JE, Perrier ND. Considering Postoperative Functional Hypoaldosteronism after Unilateral Adrenalectomy. Am Surg 83(6):598-604, 2017. e-Pub 2017. PMID: 28637561.
- Khan, MI, Waguespack, SG, Aloia, TA, Grubbs EG, Habra MA. De Novo Development of a Cortisol-Producing Adrenocortical Carcinoma in a Patient with Primary Adrenal Insufficiency - Case Study. AACE CLINICAL CASE REPORTS 3(2):e162-e165. e-Pub 2017.
- Clarke CN, Patel SH, Day RW, George S, Sweeney C, Monetes De Oca GA, Aiss MA, Grubbs EG, Bednarski BK, Lee JE, Bodurka DC, Skibber JM, Aloia TA. Implementation of a standardized electronic tool improves compliance, accuracy, and efficiency of trainee-to-trainee patient care handoffs after complex general surgical oncology procedures. Surgery 161(3):869-875, 2017. e-Pub 2017. PMID: 27825699.
- Bagheri-Yarmand R, Williams MD, Grubbs EG, Gagel RF. ATF4 Targets RET for Degradation and is a Candidate Tumor Suppressor Gene in Medullary Thyroid Cancer. J Clin Endocrinol Metab 102(3):933-941, 2017. e-Pub 2017. PMID: 27935748.
- Silva-Figueroa AM, Hess KR, Williams MD, Clarke CN, Christakis I, Graham PH, Grubbs EG, Lee JE, Busaidy NL, Perrier ND. Prognostic Scoring System to Risk Stratify Parathyroid Carcinoma. J Am Coll Surg pii: S1072-7515(17):30179-5, 2017. e-Pub 2017. PMID: 28427885.
- Altinmakas E, Hobbs BP, Ye H, Grubbs EG, Perrier ND, Prieto VG, Lee JE, Ng CS. Diagnostic performance of 18-F-FDG-PET-CT in adrenal lesions using histopathology as reference standard. Abdom Radiol (NY) 42(2):577-584, 2017. e-Pub 2017. PMID: 27665482.
- Silva AM, Vodopivec D, Christakis I, Lyons G, Wei Q, Waguespack SG, Petak SM, Grubbs E, Lee JE, Perrier N. Operative intervention for primary hyperparathyroidism offers greater bone recovery in patients with sporadic disease than in those with multiple endocrine neoplasia type 1-related hyperparathyroidism. Surgery 161(1):107-115, 2017. e-Pub 2017. PMID: 27842919.
- Xu, JY, Murphy, WA, Milton DR, Jimenez, C, Rao, SN, Habra MA, Maguespack, SG, Dadu, R, Gagel RF, Ying, AK, Cabanillas, ME, Weitzman SP, Busaidy, NL, Sellin, RV, Grubbs E, Sherman, SI, Hu MI. Bone Metastases and Skeletal-Related Events in Medullary Thyroid Carcinoma. J Clin Endocrinol Metab 101(12):4871-4877, 2016. e-Pub 2016. PMID: 27662441.
- Xu JY, Grubbs EG, Waguespack SG, Jimenez C, Gagel RF, Sosa JA, Vassilopoulou-Sellin R, Dadu R, Hu MI, Trotter CS, Jackson M, Rich TA, Hyde SM, Sherman SI, Cote GJ. Medullary Thyroid Carcinoma Associated with Germline RET K666N Mutation. Thyroid 26(12):1744-1751, 2016. e-Pub 2016. PMID: 27673361.
- Long KL, Etzel C, Rich T, Hyde S, Perrier ND, Graham PH, Lee JE, Hu MI, Cote GJ, Gagel R, Grubbs EG. All in the family? Analyzing the impact of family history in addition to genotype on medullary thyroid carcinoma aggressiveness in MEN2A patients. Fam Cancer 16(2):283-289, 2016. e-Pub 2016. PMID: 27864651.
- Grubbs EG, Williams MD, Scheet P, Vattathil S, Perrier N, Lee JE, Gagel RF, Hai T, Feng L, Cabanillas M, Cote GJ. The role of CDKN2C copy number in sporadic medullary thyroid carcinoma. Thyroid 26(11):1553-1562, 2016. e-Pub 2016. PMID: 27610696.
- Christakis I, Silva AM, Kwatampora LJ, Warneke CL, Clarke CN, Williams MD, Grubbs EG, Lee JE, Busaidy NL, Perrier ND. Oncologic progress for the treatment of parathyroid carcinoma is needed. J Surg Oncol 11(6):708-713, 2016. e-Pub 2016. PMID: 27753088.
- Christakis I, Bussaidy N, Clarke C, Kwatampora LJ, Warneke CL, Silva AM, Williams MD, Grubbs EG, Lee JE, Perrier ND. Differentiating Atypical Parathyroid Neoplasm from Parathyroid Cancer. Ann Surg Oncol 23(9):2889-97, 2016. e-Pub 2016. PMID: 27160525.
- Christakis I, Qiu W, Silva Figueroa AM, Hyde S, Cote GJ, Busaidy NL, Williams M, Grubbs E, Lee JE, Perrier ND. Clinical Features, Treatments, and Outcomes of Patients with Thymic Carcinoids and Multiple Endocrine Neoplasia Type 1 Syndrome at MD Anderson Cancer Center. Horm Cancer 7(4):279-289, 2016. e-Pub 2016. PMID: 27311764.
- Christakis IA, Potylchansky E, Silva AM, Nates JP, Prieto PA, Graham PH, Grubbs EG, Lee JE, Perrier ND. Cervical hematoma following an endocrine surgical procedure: The MD Anderson experience. Surgery 160(2):377-83, 2016. e-Pub 2016. PMID: 27063343.
- Starker LF, Prieto PA, Liles JS, Tran Cao HS, Grubbs EG, Lee JE, Perrier ND, Graham PH. Endocrine incidentalomas. Curr Probl Surg 53(5):219-46, 2016. e-Pub 2016. PMID: 27325542.
- Day RW, Fleming J, Katz MH, Grubbs E, Bednarski BK, Lee JE, Aloia TA. Rapid assessment of technical competency: the 8-min suture test. J Surg Res 200(1):46-52, 2016. e-Pub 2016. PMID: 26276369.
- Cabanillas ME, Dadu R, Hu MI, Lu C, Gunn GB, Grubbs EG, Lai SY, Williams MD. Thyroid Gland Malignancies. Hematol Oncol Clin North Am 29(16):1123-43, 2015. e-Pub 2015. PMID: 26568552.
- Vodopivec DM, Habra MA, Ng C, Sircar K, Grubbs EG. Giant Adrenal Myelolipoma in the Context of Congenital Adrenal Hyperplasia. Endocr Pract 21(7):854, 2015. e-Pub 2015. PMID: 26121444.
- Grubbs EG, Ng PK, Bui J, Busaidy NL, Chen K, Lee JE, Lu X, Lu H, Meric-Bernstam F, Mills GB, Palmer G, Perrier ND, Scott KL, Shaw KR, Waguespack SG, Williams MD, Yelensky R, Cote GJ. RET fusion as a novel driver of medullary thyroid carcinoma. J Clin Endocrinol Metab 100(3):788-93, 2015. e-Pub 2015. PMID: 25546157.
- Dy BM, Strajina V, Cayo AK, Richards ML, Farley DR, Grant CS, Harmsen WS, Evans DB, Grubbs EG, Bible KC, Young WF, Perrier ND, Que FG, Nagorney DM, Lee JE, Thompson GB. Surgical resection of synchronously metastatic adrenocortical cancer. Ann Surg Oncol 22(1):145-51, 2015. e-Pub 2015. PMID: 25092161.
- Dadu R, Hu MN, Grubbs EG, Gagel RF. Use of Tyrosine Kinase Inhibitors for Treatment of Medullary Thyroid Carcinoma. Recent Results in Cancer Res(204):227-49, 2015. e-Pub 2015.
- Romero Arenas MA, Fowler RG, San Lucas FA, Shen J, Rich TA, Grubbs EG, Lee JE, Scheet P, Perrier ND, Zhao H. Preliminary whole-exome sequencing reveals mutations that imply common tumorigenicity pathways in multiple endocrine neoplasia type 1 patients. Surgery 156(6):1351-8, 2014. e-Pub 2014. PMID: 25456907.
- Morris LF, Romero Arenas MA, Cerny J, Berger JS, Borror CM, Ong M, Cayo AK, Graham PH, Grubbs EG, Lee JE, Perrier ND. Streamlining variability in hospital charges for standard thyroidectomy: Developing a strategy to decrease waste. Surgery 156(6):1141-9, 2014. e-Pub 2014. PMID: 25456929.
- Morris LF, Lee S, Warneke CL, Abadin SS, Suliburk JW, Romero Arenas MA, Lee JE, Grubbs EG, Perrier ND. Fewer adverse events after reoperative parathyroidectomy associated with initial minimally invasive parathyroidectomy. Am J Surg 208(5):850-5, 2014. e-Pub 2014. PMID: 25152254.
- Rich TA, Feng L, Busaidy N, Cote GJ, Gagel RF, Hu MI, Jimenez C, Lee JE, Perrier N, Sherman SI, Waguespack SG, Ying AK, Grubbs EG. Prevalence by Age and Predictors of Medullary Thyroid Cancer in Patients with Lower Risk Germline RET Proto-Oncogene Mutations. Thyroid 24(7):1096-106, 2014. e-Pub 2014. PMID: 24617864.
- Lee S, Ryu H, Morris LF, Grubbs EG, Lee JE, Harun N, Feng L, Perrier ND. Operative failure in minimally invasive parathyroidectomy utilizing an intraoperative parathyroid hormone assay. Ann Surg Oncol 21(6):1878-83, 2014. e-Pub 2014. PMID: 24452409.
- Romero Arenas MA, Sui D, Grubbs EG, Lee JE, Perrier ND. Adrenal Metastectomy is Safe in Selected Patients. World J Surg 38(6):1336-42, 2014. e-Pub 2014. PMID: 24452292.
- Bednarski BK, Habra MA, Phan A, Milton DR, Wood C, Vauthey N, Evans DB, Katz MH, Ng CS, Perrier ND, Lee JE, Grubbs EG. Borderline Resectable Adrenal Cortical Carcinoma: A Potential Role for Preoperative Chemotherapy. World J Surg 38(6):1318-27, 2014. e-Pub 2014. PMID: 24615603.
- Rich TA, Liu M, Etzel CJ, Bannon SA, Mork ME, Ready K, Saraiya DS, Grubbs EG, Perrier ND, Lu KH, Arun BK, Woodard TL, Schover LR, Litton JK. Comparison of attitudes regarding preimplantation genetic diagnosis among patients with hereditary cancer syndromes. Fam Cancer 13(2):291-9, 2014. e-Pub 2014. PMID: 24072553.
- Holsinger FC, Ramaswamy U, Cabanillas ME, Lang J, Lin HY, Busaidy NL, Grubbs E, Rahim S, Sturgis EM, Lee JE, Weber RS, Clayman GL, Rohren EM. Measuring the extent of total thyroidectomy for differentiated thyroid carcinoma using radioactive iodine imaging: relationship with serum thyroglobulin and clinical outcomes. JAMA Otolaryngol Head Neck Surg 140(5):410-5, 2014. e-Pub 2014. PMID: 24700275.
- Romero Arenas MA, Morris LF, Rich TA, Cote GJ, Grubbs EG, Waguespack SG, Perrier ND. Preoperative multiple endocrine neoplasia type 1 diagnosis improves the surgical outcomes of pediatric patients with primary hyperparathyroidism. J Pediatr Surg 49(4):546-50, 2014. e-Pub 2014. PMID: 24726110.
- Abadin SS, Ayala-Ramirez M, Jimenez C, Dickson PV, Liang Y, Lazar AJ, Hornick JL, Cotton M, Sui D, Rich T, Lee JE, Grubbs E, Perrier ND. Impact of Surgical Resection for Subdiaphragmatic Paragangliomas. World J Surg 38(3):733-41, 2014. e-Pub 2014. PMID: 24390286.
- Romero Arenas MA, Ryu H, Lee S, Morris LF, Grubbs EG, Lee JE, Perrier ND. The Role of Thyroidectomy in Metastatic Disease to the Thyroid Gland. Ann Surg Oncol 21(2):434-9, 2014. e-Pub 2014. PMID: 24081800.
- Cabanillas ME, Mimi H, Camilo J, Grubbs EG, Cote GJ. Treating medullary thyroid cancer in the age of targeted therapy. Int. J. Endo. Oncol 1(2):203–216, 2014. e-Pub 2014. PMID: 25908961.
- Morris LF, Harris RS, Milton DR, Waguespack SG, Habra MA, Jimenez C, Vassilopoulou-Sellin R, Lee JE, Perrier ND, Grubbs EG. Impact and timing of bilateral adrenalectomy for refractory adrenocorticotropic hormone-dependent Cushing's syndrome. Surgery 154(6):1174-83; discussion 1183-4, 2013. e-Pub 2013. PMID: 24383115.
- Wisniewski WR, Fournier KF, Ling YK, Slack RS, Babiera G, Grubbs EG, Moore LJ, Fleming JB, You YN. A focused curriculum in surgical oncology for the third-year medical students. J Surg Res 185(2):555-60, 2013. e-Pub 2013. PMID: 23845865.
- Cooper AB, Habra MA, Grubbs EG, Bednarski BK, Ying AK, Perrier ND, Lee JE, Aloia TA. Does laparoscopic adrenalectomy jeopardize oncologic outcomes for patients with adrenocortical carcinoma?. Surg Endosc 27(11):4026-32, 2013. e-Pub 2013. PMID: 23765427.
- Morris LF, Iupe IM, Edeiken-Monroe BS, Warneke CL, Hansen MO, Evans DB, Lee JE, Grubbs EG, Perrier ND. Pre-operative ultrasound identification of thyroiditis helps predict the need for thyroid hormone replacement after thyroid lobectomy. Endocr Pract 19(9):1015-20, 2013. e-Pub 2013. PMID: 24013973.
- Lee S, Skelton TS, Zheng F, Schwartz KA, Perrier ND, Lee JE, Bassett RL, Ahmed S, Krishnamurthy S, Busaidy NL, Grubbs EG. The Biopsy-Proven Benign Thyroid Nodule: Is Long-Term Follow-Up Necessary?. J Am Coll Surg 217(1):81-88, 2013. e-Pub 2013. PMID: 23659946.
- Grubbs EG, Rich TA, Ng C, Bhosale PR, Jimenez C, Evans DB, Lee JE, Perrier ND. Long-term outcomes of surgical treatment for hereditary pheochromocytoma. J Am Coll Surg 216(2):280-9, 2013. e-Pub 2013. PMID: 23317575.
- Habra MA, Ejaz S, Feng L, Das P, Deniz F, Grubbs EG, Phan A, Waguespack SG, Ayala-Ramirez M, Jimenez C, Perrier ND, Lee JE, Vassilopoulou-Sellin R. A retrospective cohort analysis of the efficacy of adjuvant radiotherapy after primary surgical resection in patients with adrenocortical carcinoma. J Clin Endocrinol Metab 98(1):192-7, 2013. e-Pub 2013. PMID: 23150683.
- Dickson PV, Alex GC, Grubbs EG, Jimenez C, Lee JE, Perrier ND. Robotic-assisted retroperitoneoscopic adrenalectomy: making a good procedure even better. Am Surg 79(1):84-9, 2013. e-Pub 2013. PMID: 23317617.
- Morris LF, Waguespack SG, Edeiken-Monroe BS, Lee JE, Rich TA, Ying AK, Warneke CL, Evans DB, Perrier ND, Grubbs EG. Ultrasonography should not guide the timing of thyroidectomy in pediatric patients diagnosed with multiple endocrine neoplasia syndrome 2A through genetic screening. Ann Surg Oncol 20(1):53-9, 2013. e-Pub 2013. PMID: 22890595.
- Morris LF, Waguespack SG, Warneke CL, Ryu H, Ying AK, Anderson BJ, Sturgis EM, Clayman GL, Lee JE, Evans DB, Grubbs EG, Perrier ND. Long-term follow-up data may help manage patient and parent expectations for pediatric patients undergoing thyroidectomy. Surgery 152(6):1165-71, 2012. e-Pub 2012. PMID: 23158186.
- Morris GS, Landry CL, Grubbs EG, Jimenez C, Busaidy NL, Perrier ND. Greater than age-predicted functional deficits in older patients with primary hyperparathyroidism. Endocr Pract 18(4):450-5, 2012. e-Pub 2012. PMID: 22784831.
- Landry CS, Grubbs EG, Warneke CL, Ormond M, Chua C, Lee JE, Perrier N. Robot-assisted transaxillary thyroid surgery in the United States: is it comparable to open thyroid lobectomy?. Ann Surg Oncol 19(4):1269-74, 2012. e-Pub 2012. PMID: 22065191.
- Harris R, Ryu H, Vu T, Kim E, Edeiken B, Grubbs EG, Perrier ND. Modern approach to surgical intervention of the thyroid and parathyroid glands. Semin Ultrasound CT MR 33(2):115-22, 2012. e-Pub 2012. PMID: 22410359.
- Landry CS, Grubbs EG, Hernandez M, Hu MI, Hansen MO, Lee JE, Perrier ND. Predictable criteria for selective, rather than routine, calcium supplementation following thyroidectomy. Arch Surg 147(4):338-44, 2012. e-Pub 2012. PMID: 22184134.
- Abbott DE, Cantor SB, Grubbs EG, Santora R, Gomez HF, Evans DB, Lee JE, Vu T, Perrier ND. Outcomes and Economic Analysis of Routine Preoperative 4-Dimensional CT for Surgical Intervention in de novo Primary Hyperparathyroidism: Does Clinical Benefit Justify the Cost?. J Am Coll Surg 214(4):629-37, 2012. e-Pub 2012. PMID: 22321526.
- Akay CL, Mer-Bernstam F, Hunt KK, Grubbs EG, Bedrosian I, Tucker SL, Kuerer HM, Hoffman KE, Babiera GV, Strom EA, Buchholz TA, Mittendorf EA. Evaluation of the MD Anderson Prognostic Index for Local-Regional Recurrence After Breast Conserving Therapy in Patients Receiving Neoadjuvant Chemotherapy. Ann Surg Oncol 19(3):901-907, 2012. e-Pub 2012. PMID: 21861223.
- Zhang HM, Perrier ND, Grubbs EG, Sircar K, Ye ZX, Lee JE, Ng CS. CT features and quantification of the characteristics of adrenocortical carcinomas on unenhanced and contrast-enhanced studies. Clin Radiol 67(1):38-46, 2012. e-Pub 2012. PMID: 21783181.
- Dickson PV, Rich TA, Xing Y, Cote GJ, Wang H, Perrier ND, Evans DB, Lee JE, Grubbs EG. Achieving eugastrinemia in MEN1 patients: both duodenal inspection and formal lymph node dissection are important. Surgery 150(6):1143-1152, 2011. e-Pub 2011. PMID: 22136834.
- Dickson PV, Alex GC, Grubbs EG, Ayala-Ramirez M, Jimenez C, Evans DB, Lee JE, Perrier ND. Posterior retroperitoneoscopic adrenalectomy is a safe and effective alternative to transabdominal laparoscopic adrenalectomy for pheochromocytoma. Surgery 150(3):452-458, 2011. e-Pub 2011. PMID: 21878230.
- Moreno MA, Callender G, Woodburn K, Edeiken-Monroe BS, Grubbs EG, Evans DB, Lee JE, Perrier ND. Common locations of parathyroid adenomas. Ann Surg Oncol 18(4):1047-51, 2011. e-Pub 2011. PMID: 21104031.
- Landry CS, Grubbs EG, Morris GS, Turner NS, Holsinger FC, Lee JE, Perrier ND. Robot assisted transaxillary surgery (RATS) for the removal of thyroid and parathyroid glands. Surgery 149(4):549-55, 2011. e-Pub 2011. PMID: 20947113.
- Dickson PV, Jimenez C, Chisholm GB, Kennamer DL, Ng C, Grubbs EG, Evans DB, Lee JE, Perrier ND. Posterior retroperitoneoscopic adrenalectomy: a contemporary American experience. J Am Coll Surg 212(4):659-65, 2011. e-Pub 2011. PMID: 21463807.
- Landry CS, Grubbs EG, Busaidy NL, Monroe BJ, Staerkel GA, Perrier ND, Edeiken-Monroe BS. Cystic lymph nodes in the lateral neck as indicators of metastatic papillary thyroid cancer. Endocr Pract 17(2):240-4, 2011. e-Pub 2011. PMID: 20713342.
- Jasim S, Ying AK, Waguespack SG, Rich TA, Grubbs EG, Jimenez C, Hu MI, Cote G, Habra MA. Multiple endocrine neoplasia type 2B with a RET pronto-oncogene A883F mutation displays a more indolent form of medullary thyroid carcinoma compared with a RET M9181T mutation. Thyroid 21(2):189-92, 2011. e-Pub 2011. PMID: 21186952.
- Grubbs EG, Waguespack SG, Rich TA, Xing Y, Ying AK, Evans DB, Lee JE, Perrier ND. Do the recent American Thyroid Association Guidelines accurately guide the timing of prophylactic thyroidectomy in MEN2A?. Surgery 148(6):1302-1310, 2010. e-Pub 2010. PMID: 21134565.
- Silberfein EJ, Bao R, Lopez A, Grubbs EG, Lee JE, Evans DB, Perrier ND. Reoperative Parathyroidectomy: location of missed glands based on a contemporary nomenclature system. Archives of Surgery 145(11):1065-1068, 2010. e-Pub 2010. PMID: 21079094.
- Landry CS, Grubbs EG, Perrier ND. Bilateral robotic-assisted transaxillary surgery. Arch Surg 145(8):717-20, 2010. e-Pub 2010. PMID: 20713921.
- Pettiford J, Erasmus J, Grubbs EG, Perrier ND. Dysphagia lucoria: Consideration for the endocrine surgeon. Surgery 147(6):890-2, 2010. e-Pub 2010. PMID: 20004435.
- Waguespack SG, Rich T, Grubbs EG, Ying AK, Perrier ND, Ayala-Ramirez M, Jimenez C. A Current Review of the Etiology, Diagnosis, and Treatment of Pediatric Pheochromocytoma and Paraganglioma. J Clin Endocrinol Metab 95(5):2023-2037, 2010. e-Pub 2010. PMID: 20215394.
- Morris GS, Grubbs EG, Hearon CM, Gantela S, Lee JE, Evans DB, Holmes HM, Busaidy NL, Jimenez C, Perrier ND. Parathyroidectomy improves functional capacity in "asymptomatic" older patients with primary hyperparathyroidism: a randomized control trial. Ann Surg 251(5):832-7, 2010. e-Pub 2010. PMID: 20395857.
- Grubbs EG, Callender GG, Xing Y, Perrier ND, Evans DB, Phan AT, Lee JE. Recurrence of Adrenal Cortical Carcinoma Following Resection: Surgery Alone Can Achieve Results Equal to Surgery Plus Mitotane. Ann Surg Oncol 17(1):263-70, 2010. e-Pub 2010. PMID: 19851811.
- Perrier ND, Balachandran D, Wefel JS, Jimenez C, Busaidy N, Morris GS, Dong W, Jackson E, Weaver S, Gantela S, Evans DB, Grubbs EG, Lee JE. Prospective, randomized, controlled trial of parathyroidectomy versus observation in patients with "asymptomatic" primary hyperparathyroidism. Surgery 146(6):1116-22, 2009. e-Pub 2009. PMID: 19879613.
- Grubbs EG, Lee JE. Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma: proposal for a revised TNM classification. Cancer 115(24):5847, 2009. e-Pub 2009. PMID: 19827149.
- Marshall CL, Lee JE, Xing Y, Perrier ND, Edeiken BS, Evans DB, Grubbs EG. Routine pre-operative ultrasonography for papillary thyroid cancer: Effects on cervical recurrence. Surgery 146(6):1063-72, 2009. e-Pub 2009. PMID: 19958933.
- Callender GG, Kennamer DL, Grubbs EG, Lee JE, Evans DB, Perrier ND. Posterior Retroperitoneoscopic Adrenalectomy. Adv Surg 43(1):147-157, 2009. e-Pub 2009. PMID: 19845175.
- Callender GG, Grubbs EG, Vu T, Hofstetter WL, Fleming JB, Woodburn KL, Lee JE, Evans DB, Perrier ND. The fallen one: the inferior parathyroid gland that descends into the mediastinum. J Am Coll Surg 208(5):887-93; discussion 893-5, 2009. e-Pub 2009. PMID: 19476855.
- Grubbs EG, Rafeeq S, Jimenez C, Feng L, Lee JE, Evans DB, Perrier ND. Preoperative Vitamin D Replacement Therapy in Primary Hyperparathyroidism: Safe and Beneficial?. Surgery 144(6):852-8, 2008. e-Pub 2008. PMID: 19040987.
- Perrier ND, Kennamer DL, Bao R, Jimenez C, Grubbs EG, Lee JE, Evans DB. Posterior retroperitoneoscopic adrenalectomy: preferred technique for removal of benign tumors and isolated metastases. Ann Surg 248(4):666-74, 2008. e-Pub 2008. PMID: 18936580.
- Grubbs EG, Rich TA, Li G, Sturgis EM, Younes MN, Myers JN, Edeiken-Monroe B, Fornage BD, Monroe DP, Staerkel GA, Williams MD, Waguespack SG, Hu MI, Cote G, Gagel RF, Cohen J, Weber RS, Anaya DA, Holsinger FC, Perrier ND, Clayman GL, Evans DB. Recent advances in thyroid cancer. Curr Probl Surg 45(3):156-250, 2008. e-Pub 2008. PMID: 18346477.
- Grubbs EG, Rich TA, Li G, Sturgis EM, Younes MN, Myers JN, Edeiken-Monroe B, Fornage BD, Monroe DP, Staerkel GA, Williams MD, Waguespack SG, Hu MI, Cote G, Gagel RF, Cohen J, Weber RS, Anaya DA, Holsinger FC, Perrier ND, Clayman GL, Evans DB. Recent advances in thyroid cancer. In brief. Curr Probl Surg 45(3):149-51, 2008. e-Pub 2008. PMID: 18346476.
- Grubbs EG, Abdel-Wahab Z, Pruitt SK, Tyler DS. Utilizing quantitative polymerase chain reaction to evaluate prostate stem cell antigen as a tumor marker in pancreatic cancer. Ann Surg Oncol 13(12):1645-54, 2006. e-Pub 2006. PMID: 16957968.
- Ueno T, Ko SH, Grubbs EG, Yoshimoto Y, Augustine C, Abdel-Wahab Z, Cheng TY, Abdel-Wahab OI, Pruitt SK, Friedman HS, Tyler DS. Modulation of chemotherapy resistance in regional therapy: a novel therapeutic approach to advanced extremity melanoma using intra-arterial temozolomide in combination with systemic O6-benzylguanine. Mol Cancer Ther 5(3):732-8, 2006. e-Pub 2006. PMID: 16546988.
- Aloia TA, Grubbs EG, Onaitis M, Mosca PJ, Cheng TY, Seigler H, Tyler DS. Predictors of outcome after hyperthermic isolated limb perfusion: role of tumor response. Archives of Surgery 140(11):1115-20, 2005. e-Pub 2005. PMID: 16301451.
- Ueno T, Ko SH, Grubbs EG, Pruitt SK, Friedman HS, Tyler DS. Temozolomide is a novel regional infusion agent for the treatment of advanced extremity melanoma. Am J Surg 188(5):532-7, 2004. e-Pub 2004. PMID: 15546565.
- Grubbs EG, Abdel-Wahab O, Cheng TY, Abdel-Wahab Z, Peterson B, Pruitt SK, Colvin OM, Friedman HS, Tyler DS. In-transit Melanoma: The Role of Alkylating Agent Resistance in Regional Therapy. J Am Coll Surg 199(3):419-27, 2004. e-Pub 2004. PMID: 15325612.
- Abdel-Wahab OI, Grubbs EG, Vigliani BL, Ty C, Ueno T, Ko S, Rabbani Z, Curtis S, Pruitt SK, Dewhirst MW, Tyler DS. The role of hyperthermia in regional alkylating agent chemotherapy. Clinical Cancer Research 10(17):5919-29, 2004. e-Pub 2004. PMID: 15355925.
- Grubbs EG, Ueno T, Abdel-Wahab O, Cheng TY, Pruitt SK, Colvin MO, Friedman HS, Tyler DS. Modulation of resistance to regional chemotherapy in the extremity melanoma model. Surgery 136(2):210-8, 2004. e-Pub 2004. PMID: 15300182.
- Cheng TY, Grubbs EG, Abdul-Wahab O, Leu SY, Hung CF, Petros W, Slois T, Fedrau R, Pruitt S, Colvin M, Freidman H, Tyler DS. Marked variability of melphalan plasma drug levels during regional hyperthermic isolated limb perfusion. American Journal of Surgery 186(5):460-7, 2003. e-Pub 2003. PMID: 14599607.
- Reynolds JD, Grubbs EG, Dexter F, Punnahitananda S, Dense TA, Penning DH. Acute cord occlusion increases blood ionized magnesium concentration in preterm fetal sheep during maternal magnesium sulfate exposure. Can J Physiol Pharmacol 78(4):301-6, 2000. e-Pub 2000. PMID: 10772057.
Invited Articles
- Romero Arenas MA, Grubbs EG. ASO Author Reflections: Informing Patients About New Genetic Testing. Ann Surg Oncol 26(Supp 3):559-560, 2019. e-Pub 2019. PMID: 30617867.
- Wach MM, Grubbs EG, D'Angelica M, Hernandez JM. ASO Author Reflections: Complex General Surgical Oncology Fellowships: What Are Programs Looking For?. Ann Surg Oncol 26(9):2682-2683, 2019. e-Pub 2019. PMID: 31243664.
- Grubbs EG, Gagel RF. My, How Things Have Changed in Multiple Endocrine Neoplasia Type 2A!. J Clin Endocrinol Metab 100(7):2532-5, 2015. e-Pub 2015. PMID: 26151398.
- Landry CS, Ruppe MD, Grubbs EG. Vitamin D receptors and parathyroid glands. Endocr Pract 1:63-68, 2011. e-Pub 2011. PMID: 21454240.
- Landry CS, Grubbs EG, Lee JE, Perrier ND. From scalpel to console: a suggested model for surgical skill acquisition. Bull Am Coll Surg 95(8):20-4, 2010. e-Pub 2010. PMID: 21462775.
- Grubbs EG, Lee JE. Walz aldosteronoma. World J Surg 32(5):854-5, 2008. e-Pub 2008. PMID: 18246389.
Review Articles
- Santillan MR, Dadu R, Gagel RF, Grubbs EG, Hu MI. Systemic Therapies for Advanced Medullary Thyroid Carcinoma. Recent Results Cancer Res 223:293-307, 2025. e-Pub 2025. PMID: 40102263.
- Bagheri-Yarmand R, Grubbs EG, Hofmann MC. Thyroid C-Cell Biology and Oncogenic Transformation. Recent Results Cancer Res 223:51-91, 2025. e-Pub 2025. PMID: 40102254.
- Dadu R, Bagheri-Yarmand R, Ringel MD, Grubbs EG, Zafereo M, Cote G, Gagel RF, Robinson BG, Shaw KR, Hu MI. HEREDITARY ENDOCRINE TUMOURS: CURRENT STATE-OF-THE-ART AND RESEARCH OPPORTUNITIES: The state of science in medullary thyroid carcinoma: current challenges and unmet needs. Endocr Relat Cancer 27(8):T27-T39, 2020. e-Pub 2020. PMID: 32580150.
- Dadu R, Hu MN, Grubbs EG, Gagel RF. Use of Tyrosine Kinase Inhibitors for Treatment of Medullary Thyroid Carcinoma. Recent Results Cancer Res 204:227-49, 2015. e-Pub 2015. PMID: 26494392.
- Cote GJ, Grubbs EG, Hofmann MC. Thyroid C-Cell Biology and Oncogenic Transformation. Recent Results Cancer Res 204:1-39, 2015. e-Pub 2015. PMID: 26494382.
- Grubbs EG, Evans DB. Role of lymph node dissection in primary surgery for thyroid cancer. J Natl Compr Canc Netw 5(6):623-30, 2007. e-Pub 2007. PMID: 17623613.
Editorials
- Lillemoe HA, Grubbs EG. Distinguished moderator commentary on Competency-based education across the surgery continuum. Surgery 177(108875), 2025. PMID: 39488454.
- Szabo Yamashita, T, Grubbs, EG. Medullary Thyroid Carcinoma. Annals of surgical oncology 31(2):709-710, 2024. PMID: 38032463.
- Grubbs EG, Halperin DM, Waguespack SG, Gagel RF. History of the multiple endocrine neoplasia workshops and overview of MEN2019. Endocr Relat Cancer, 2020. PMID: 32508314.
Abstracts
- Morris LF, Harris RS, Milton DR, Waguespack SG, Habra MA, Jimenez C, Vassilopoulou-Sellin R, Lee JE, Perrier ND, Grubbs EG. Impact and Timing of Bilateral Adrenalectomy for Refractory ACTH-Dependent Cushing's Syndrome, AAES 39th Annual Meeting, 2013. e-Pub 2013.
- Lee S, Skelton TS, Zheng F, Schwartz KA, Perrier ND, Lee JE, Bassett RL, Ahmaed S, Krishnamurthy S, Busaidy NL, Grubbs EG. The Biopsy-Proven Benign Thyroid Nodule: Is Long-Term Follow-Up Necessary?. Western Surgical Association Annual Meeting, Colorado Springs, 2012. e-Pub 2012.
- GS Morris GS, CL Landry CL, Grubbs EG, Jimenez C, NL Busaidy NL, ND Perrier ND. Greater than age-predicted functional deficits in older patients with primary hyperparathyroidism. Endocrine Practice 18, 2012. e-Pub 2012.
- Morris LF, Waguespack SG, Edeiken-Monroe BS, Rich TA, Warneke CL, Evans DB, Perrier ND, Grubbs EG. Ultrasonography should not guide the timing of thyroidectomy in pediatric patients diagnosed with multiple endocrine neoplasia syndrome 2A through genetic screening. Society of Surgical Oncology 65th Annual Cancer Symposium, Orlando, Florida, 2012. e-Pub 2012.
- Dickson PV, Rich TA, Xing Y, Cote CJ, Wang H, Perrier ND, Evans DB, Lee JE, Grubbs EG. Achieving eugastrinemia in MEN1 patients: Both duodenal inspection and formal lymph node dissection are important. AAES 32nd Annual Meeting, 2011. e-Pub 2011.
- Grubbs EG, Waguespack SG, Rich TA, Xing Y, Ying AK, Evans DB, Lee JE, Perrier ND. Do the recent American Thyroid Association Guidelines accurately guide the timing of prophylactic thyroidectomy in MEN2A?. AAES 32nd Annual Meeting, Pittsburgh, PA, 2010. e-Pub 2010.
- Landry CS, Rich T, Jimenez C, Busaidy NL, Grubbs EG, Lee JE, Hai T, Cote G, Gagel RF, Perrier ND. Screening for Multiple Endocrine Neoplasia 1 in Young Patients with Primary Hyperparathyroidism. MEN 2010, 12th International Workshop on Multiple Endocrine Neoplasia, 2010. e-Pub 2010.
- Rich T, Waguespack S, Gagel R, Cote G, Ying A, Hu M, Perrier ND, Lee JE, Grubbs EG. Age-Specific Identification of Medullary Thyroid Cancer in Presymptomatically Screened American Thyroid Cancer Levels A and B Ret Mutation Carriers. MEN 2010, 12th International Workshop on Multiple Endocrine Neoplasia, 2010. e-Pub 2010.
- Landry CS, Perrier ND, Karp DD, Xing Y, Lee JE, and Grubbs EG. Outcome of patients with adrenal metastasis from lung cancer: Selection criteria for surgery. American Society of Clinical Oncology Annual Meeting, 2010. e-Pub 2010.
- Grubbs EG, Callender GG, Perrier ND, Phan AT, Lee JE. Mitotane for treatment of advanced adrenal cortical carcinoma(ACC): relationship of drug level and length of treatment to disease progression. 2009 IAES Conference, Adelaide, Australia, 2009. e-Pub 2009.
- Grubbs EG, Xing Y, Callender GG, Perrier ND, Evans DB, Phan AT, Lee JE. Comparison of adrenal cortical carcinoma (ACC) staging systems by combined large database analysis. 2009 IAES Conference, Adelaide, Australia, 2009. e-Pub 2009.
- Grubbs EG, Marshall CL, Evans DB, Lee JE, Perrier ND, Edeiken BS. Routine Preoperative Ultrasound for Papillary Thyroid Cancer: Long-Term Results in 236 PATIENTS. AAES 30th Annual Meeting, Madison, Wisonsin, 2009. e-Pub 2009.
- Grubbs EG, Mittendorf EA, Phan AT, Perrier ND, Evans DB, Callender GG, Xing Y, Lee JE. Recurrence of Adrenocortical Carcinoma Following Resection: Surgery Alone can Achieve Results Equal to Surgery Plus Mitotane. Society of Surgical Oncology, 62nd Annual Cancer Symposium, 2009. e-Pub 2009.
- Grubbs EG, Lee JE, Rafeeq S, Gagel RF, Jimenez C, Feng L, Perrier ND. Preoperative Vitamin D (VitD) Replacement Therapy in Primary Hyperparathyroidism (PHPT): Safe but Beneficial?. AAES 29th Annual Meeting, Monterey, California, 2008. e-Pub 2008.
- Grubbs EG, Mittendorf EA, Evans DB, Perrier ND, Lee JE. Intraoperative Gamma Probe Identification of Normal Parathyroid Glands During Central Neck Surgery. Montreal, CA 196(6):931-936, 2008. e-Pub 2008.
- Grubbs EG, Mittendorf EA, Evans DB, Perrier ND, Lee JE. Gamma Probe Identification of Normal Parathyroid glands During Central Neck Surgery Can Facilitate Parathyroid Preservation. Am J Surg 196(6):931-5; discussion 935-6, 2008. e-Pub 2008. PMID: 19095112.
- Grubbs EG, Gantela S, Morris GS, Perrier, ND. Parathyroidectomy Improves Functional Capacity in Geriatric Patients (pts) with Seemingly "Asymptomatic" Primary Hyperparathyroidism. Society of Surgical Oncology Annual Meeting, Chicago, IL, 2008. e-Pub 2008.
- Grubbs EG, Lee JE, Evans DB, Nunez RF, Perrier ND. SPECT/CT is useful in planning incision site for minimally invasive parathyroidectomies (MIP) in treatment of primary hyperparathyroidism (PHPT). British Association of Endocrine and Thyroid Surgeons, 2008. e-Pub 2008.
- Grubbs EG, Bentley R, Pruitt SK. Sentinel Lymph Node Biopsy in Breast Cancer: How Many Nodes Need to be Removed?. Society of Surgical Oncology Annual Meeting, Washington, DC, 2007. e-Pub 2007.
- Grubbs EG, Abdel-Wahab Z, Pruitt SK, Tyler DS. Utilizing Quantitative Polymerase Chain reaction to Evaluate Prostate Stem Cell Antigen as a Tumor Marker in Pancreatic Cancer. Society of Surgical Oncology Annual Meeting Los Angeles, CA, 2003. e-Pub 2003.
- Grubbs EG, Tyler DS. Pharmacokinetics and Drug Resistance of Alkylating Agents in Melanoma. American College of Surgeons Oncology Group Spring Meeting, Montreal, CANADA, 2003. e-Pub 2003.
- Grubbs EG, Klitzman B, Pruitt SK, Tyler DS. Microdialysis: A Novel Approach For Measuring Tissue Drug Concentrations During Isolated Limb Perfusion For Melanoma Treatment. Association of Academic Surgery Annual Meeting, Boston, MA, 2002. e-Pub 2002.
- EG G. Effects of hypoxia and magnesium sulfate on the glutamate neuronal system in near-term fetal guinea pig brain. Annual Howard Hughes Medical Institute Meeting Medical Student Fellows, Chevy Chase, MD, 1998. e-Pub 1998.
- Grubbs EG, Reynolds JD, Wainwright MS, Penning DH. Effects of magnesium sulfate exposure on outcome and fetal brain NMDA receptor population following in utero hypoxia. Annual Society for Neuroscience Meeting, Los Angeles, CA, 1998. e-Pub 1998.
- Grubbs EG, Reynolds JD, Wainwright MS, Penning DH. Nitric oxide synthase activity in fetal guinea pig brain following hypoxia and magnesium sulfate exposure. Annual Society for Obstetric Anesthesia and Perinatolgy Meeting, Vancouver, CANADA, 1998. e-Pub 1998.
Book Chapters
- Long KL, Grubbs EG. Carcinoma of the Thyroid Gland and Neoplasms of the Parathyroid Glands. In: The MD Anderson Surgical Oncology Handbook. Sixth Edition. Wolters Kluwer, 2019.
- Hu MI, Grubbs EG, Sosa JA. Medullary Thyroid Carcinoma. In: Medical Management of Thyroid Disease. Third Edition. CRS, 2019.
- Lim M, Zafereo M, Grubbs E. Locally advanced differentiated thyroid cancer. In: In: Management of Thyroid Nodules and Differentiated Thyroid Cancer: A Practical Guide (Book Review). Springer, 2016.
- Cote GJ, Grubbs EG, Hofmann MC. Thyroid C-Cell Biology and Oncogenic Transformation. In: Recent Results Cancer Res. Springer, 1-39, 2015.
- Grubbs EG, Massey BL, Evans DB, Wang TS. Medullary thyroid carcinoma. In: Sataloff’s Comprehensive Textbook of Otolaryngology Head and Neck Surgery, 2014.
- Waguespack SG, Grubbs EG, Mimi HI. Practical Application in Adult Patient Care. In: Clinical Genomics, 2013.
- Thomas RM, Habra MA, Perrier ND, Grubbs EG. Well-Differentiated Carcinoma of the Thyroid and Neoplasms of the Parathyroid Glands. In: The MD Anderson Surgical Oncology Handbook, 2012.
- Callender GG, Rich T, Lee JE, Perrier ND, Grubbs EG. Pheochromocytoma. In: Neuroendocrine Tumors, 2011.
- Lee JE, Grubbs EG. Adrenocortical Carcinoma. In: McGraw-Hill Manual Endocrine Surgery. 1. The McGraw-Hill Companies, 392, 2010.
- Grubbs EG, Nunez R, Iyer RB, Perrier ND. Adrenal Imaging. In: Endocrine Surgery: Principles and Practice. Springer, 343-357, 2009.
- Grubbs EG, Tyler DS. Neoplasms of the Small Intestine. In: Cancer Medicine, 2005.
- Grubbs EG, Ludwig KA. Hereditary Nonpolyposis Colorectal Cancer. In: Inherited Cancer Syndromes, 2003.
- Grubbs EG, Tyler DS. Neoplasms of the Vermiform Appendix and Peritoneum. In: Cancer Medicine, 2003.
- Grubbs EG, Tyler DS. Neoplasms of the Small Intestine. In: Cancer Medicine, 2003.
Letters to the Editor
- Lee JE, Grubbs EG. Observations on the ENSAT Staging System. Cancer, 2011.
Patient Reviews
CV information above last modified March 31, 2026